{
  "candidates": [
    {
      "ticker": "GOOGL",
      "sector": "Communication Services",
      "theme": "Regulatory Changes Impacting Technology and Finance",
      "factor_scores": {
        "value": 0.4666666666666667,
        "quality": 1.0,
        "growth": 0.5,
        "stability": 0.5,
        "revisions": 0.903921568627451,
        "momentum": 0.3312034078807241
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.8,
        "analyst_consensus": "Buy",
        "analyst_score": 0.8,
        "news_sentiment": "bullish",
        "news_score": 0.8,
        "key_drivers": [
          "Strong analyst consensus with 80.4% recommending Buy",
          "Recent positive news regarding partnerships and price target increases",
          "Bullish sentiment surrounding AI and technology advancements"
        ],
        "key_risks": [
          "Market volatility affecting tech stocks",
          "Potential regulatory challenges in the tech sector",
          "Competition from other tech giants"
        ],
        "price_target_upside": -3.1680186823992136
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.6256431304210766,
      "news_summary": "Canaccord Genuity has raised its price target for Alphabet Inc. (GOOGL) from $330 to $390, maintaining a Buy rating, indicating strong confidence in the stock's potential despite some near-term caution. This comes amid a broader trend of tech companies, including GOOGL, focusing on artificial intelligence advancements, which are expected to drive future growth. Additionally, competition in the AI space is intensifying, with companies like Amazon and Nvidia making significant moves to establish leadership. Overall, GOOGL remains a compelling investment option as it navigates the evolving tech landscape.",
      "price": 325.44,
      "market_cap": 3929543.810579677,
      "scored_at": "2026-01-09T06:20:36.209021"
    },
    {
      "ticker": "MRK",
      "sector": "Health Care",
      "theme": null,
      "factor_scores": {
        "value": 0.7999999999999999,
        "quality": 1.0,
        "growth": 0.2,
        "stability": 0.0,
        "revisions": 0.6555555555555556,
        "momentum": 0.45363860915827386
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.7,
        "analyst_consensus": "Buy",
        "analyst_score": 0.6,
        "news_sentiment": "bullish",
        "news_score": 0.8,
        "key_drivers": [
          "Merck in talks to acquire Revolution Medicines, indicating growth potential",
          "Recent upgrades and positive recommendations from analysts",
          "Strong performance surpassing market returns"
        ],
        "key_risks": [
          "Market volatility affecting stock performance",
          "Potential regulatory hurdles in acquisitions",
          "Dependence on successful drug development and approvals"
        ],
        "price_target_upside": 7.018650328858461
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.6126071295366374,
      "news_summary": "Merck (MRK) is currently in discussions to acquire Revolution Medicines, a cancer drugmaker valued at over $20 billion, which has positively impacted Revolution's stock price. Wolfe Research has upgraded Merck, highlighting its potential for growth beyond its flagship drug, Keytruda, while Wells Fargo has added the company to its Q1 2026 Tactical Ideas List, citing a catalyst-rich period ahead. Merck's stock recently closed at $110.99, reflecting a 2.2% increase, indicating strong market performance amid these developments.",
      "price": 110.99,
      "market_cap": 275479.66906930285,
      "scored_at": "2026-01-09T06:21:38.935436"
    },
    {
      "ticker": "V",
      "sector": "Financials",
      "theme": "Regulatory Changes Impacting Technology and Finance",
      "factor_scores": {
        "value": 0.03333333333333335,
        "quality": 1.0,
        "growth": 0.5,
        "stability": 0.5,
        "revisions": 0.9235294117647058,
        "momentum": 0.03611720985049468
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.7,
        "analyst_consensus": "Buy",
        "analyst_score": 0.8,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Strong analyst consensus with 82.4% recommending 'Buy'",
          "Recent news highlights Visa's potential as a top investment",
          "Positive valuation assessments following partnerships and services"
        ],
        "key_risks": [
          "Recent stock price decline amid market uptick",
          "Potential market volatility affecting investor sentiment",
          "Competition from other major stocks like Mastercard"
        ],
        "price_target_upside": 15.05266445220452
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.5769766365101542,
      "news_summary": "Visa Inc. (NYSE:V) has been highlighted as a strong investment option, with a recent price target set at $330 by Monness Crespi Hardt & Co. The company has seen a share price increase of 7.9% over the past month and a total shareholder return of 13.5% over the past year, indicating positive momentum. Additionally, Visa's collaboration with Deluxe to implement Visa Direct aims to enhance cash flow solutions for businesses, further solidifying its position in the payments sector. Despite a slight decline in stock price to $352.23, analysts maintain a favorable outlook on Visa's valuation and growth potential.",
      "price": 352.23,
      "market_cap": 673547.4463809277,
      "scored_at": "2026-01-09T06:21:10.761048"
    },
    {
      "ticker": "MA",
      "sector": "Financials",
      "theme": null,
      "factor_scores": {
        "value": 0.03333333333333335,
        "quality": 1.0,
        "growth": 0.5,
        "stability": 0.5,
        "revisions": 0.8222222222222222,
        "momentum": 0.1341496169656211
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.7,
        "analyst_consensus": "Buy",
        "analyst_score": 0.8,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Strong analyst consensus with 72.2% recommending a buy",
          "Positive news highlighting Mastercard as a top investment choice",
          "Growth potential in the payments sector, particularly with partnerships like Apple Card"
        ],
        "key_risks": [
          "Market volatility affecting stock performance",
          "Potential competition in the payments space",
          "Economic downturn impacting consumer spending"
        ],
        "price_target_upside": 13.765580016204924
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.5719965426068285,
      "news_summary": "Mastercard Incorporated (NYSE:MA) continues to receive positive attention from analysts, with Monness Crespi Hardt & Co. maintaining a Hold rating and a price target of $525, while Keefe, Bruyette & Woods has a Buy rating. The average brokerage recommendation for Mastercard is currently equivalent to a Buy, indicating strong market interest. As the payments landscape evolves, particularly with the transition of the Apple Card to JPMorgan, Mastercard's position in the fintech sector remains robust, making it a compelling investment option.",
      "price": 580.07,
      "market_cap": 520900.43371058715,
      "scored_at": "2026-01-09T06:21:16.192210"
    },
    {
      "ticker": "QCOM",
      "sector": "Information Technology",
      "theme": null,
      "factor_scores": {
        "value": 0.3666666666666667,
        "quality": 0.7,
        "growth": 0.5,
        "stability": 0.5,
        "revisions": 0.5324324324324324,
        "momentum": 0.527136314917665
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Hold",
        "analyst_score": 0.2,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Strong performance in AI and robotics showcased at CES 2026",
          "Positive analyst reports highlighting Qualcomm's growth potential",
          "Recognition as a high-quality dividend growth stock"
        ],
        "key_risks": [
          "Overall tech sector weakness impacting stock performance",
          "Limited number of sell recommendations indicating potential caution",
          "Market volatility affecting investor sentiment"
        ],
        "price_target_upside": 3.9203826909330814
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.5408889450690094,
      "news_summary": "Qualcomm (QCOM) recently showcased its advancements in AI and robotics at CES 2026, unveiling the Snapdragon X Plus 2 chip designed for PCs and highlighting its role in powering humanoid robots. The company's collaboration with Visteon on automotive technology was also featured, demonstrating the capabilities of its Snapdragon Cockpit Elite platform. Despite these innovations, QCOM's stock experienced a decline of 1.24%, reflecting broader tech market pressures, as the Nasdaq 100 faced challenges amid rising costs and profitability concerns for some of its constituents.",
      "price": 181.87,
      "market_cap": 194782.7726393809,
      "scored_at": "2026-01-09T06:23:48.156629"
    },
    {
      "ticker": "PFE",
      "sector": "Health Care",
      "theme": "Healthcare Innovation and Biotech Advancements",
      "factor_scores": {
        "value": 0.6,
        "quality": 0.7,
        "growth": 0.2,
        "stability": 0.5,
        "revisions": 0.4703703703703703,
        "momentum": 0.13052208835341386
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.7,
        "analyst_consensus": "Hold",
        "analyst_score": 0.1,
        "news_sentiment": "bullish",
        "news_score": 0.8,
        "key_drivers": [
          "Strong focus on AI and precision oncology enhancing investment story",
          "Positive market sentiment reflected in bullish news headlines",
          "No sell recommendations from analysts indicating stability"
        ],
        "key_risks": [
          "Current price below analyst price target may indicate market skepticism",
          "Dependence on successful AI integration in drug discovery",
          "Potential competition in oncology market"
        ],
        "price_target_upside": 11.269276393831559
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.5176791823378168,
      "news_summary": "Pfizer Inc. (PFE) has recently announced strategic collaborations with Boltz and Cartography Biosciences to leverage AI in drug discovery and enhance its oncology pipeline, reflecting a significant shift towards advanced technology in its R&D processes. Additionally, positive Phase 3 trial results for the combination of PADCEV and Keytruda in bladder cancer treatment further bolster Pfizer's position in the oncology market. These developments indicate a proactive approach to improving pipeline productivity and addressing competitive pressures in the pharmaceutical industry.",
      "price": 25.29,
      "market_cap": 143791.54707473968,
      "scored_at": "2026-01-09T06:21:33.063554"
    },
    {
      "ticker": "FSLR",
      "sector": "Utilities",
      "theme": "Energy Transition and Sustainability",
      "factor_scores": {
        "value": 0.26666666666666666,
        "quality": 0.7,
        "growth": 1.0,
        "stability": 0.0,
        "revisions": 0.8567567567567568,
        "momentum": -0.4775485204608974
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.3,
        "analyst_consensus": "Buy",
        "analyst_score": 0.5,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Strong analyst consensus with 78.4% recommending Buy",
          "Current price is below the average price target, indicating potential upside"
        ],
        "key_risks": [
          "Recent downgrade by Jefferies with a lower price target",
          "Concerns about valuation and booking issues"
        ],
        "price_target_upside": 13.627872979777472
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.5096491266532992,
      "news_summary": "First Solar (FSLR) has experienced a notable decline of 7.7% following a downgrade from Jefferies, which shifted its rating from Buy to Hold due to concerns over weaker bookings and project cancellations. Despite a strong performance over the past year, with a 28.8% return, the stock has faced a 10.2% decline year-to-date. Analysts remain divided, with some maintaining bullish views, but the recent downgrade raises questions about the stock's valuation and future growth potential in a challenging market environment.",
      "price": 246.26,
      "market_cap": 26425.70351402671,
      "scored_at": "2026-01-09T06:26:10.623424"
    },
    {
      "ticker": "REGN",
      "sector": "Health Care",
      "theme": "Healthcare Innovation and Biotech Advancements",
      "factor_scores": {
        "value": 0.7,
        "quality": 0.5,
        "growth": 0.2,
        "stability": 0.5,
        "revisions": 0.676923076923077,
        "momentum": 0.3146039272589079
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.7,
        "analyst_consensus": "Buy",
        "analyst_score": 0.6,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Strong analyst consensus with 61.5% recommending Buy",
          "Recent bullish news regarding analyst upgrades and investment interest",
          "Positive outlook despite past performance lagging behind S&P 500"
        ],
        "key_risks": [
          "One Sell recommendation indicating some skepticism",
          "Recent bearish sentiment from Upstream Bio suggesting overvaluation",
          "Potential volatility due to market conditions affecting stock performance"
        ],
        "price_target_upside": -1.300857667195161
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.49276700067747614,
      "news_summary": "Regeneron Pharmaceuticals (REGN) has recently experienced a positive shift in market sentiment, highlighted by upgrades from major banks like Bank of America and Citi, which raised their price targets significantly to $860 and $900, respectively. This comes ahead of the company's fourth-quarter earnings report scheduled for January 30, 2026, where analysts expect REGN to continue its history of earnings surprises. Additionally, a decline in short interest suggests reduced bearish sentiment among investors, indicating growing confidence in Regeneron's future prospects and pipeline updates for 2026.",
      "price": 801.01,
      "market_cap": 84185.72377560133,
      "scored_at": "2026-01-09T06:26:17.783101"
    },
    {
      "ticker": "JPM",
      "sector": "Financials",
      "theme": null,
      "factor_scores": {
        "value": 0.36666666666666664,
        "quality": 0.5,
        "growth": 0.5,
        "stability": 0.5,
        "revisions": 0.6599999999999999,
        "momentum": 0.19577721225663605
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Buy",
        "analyst_score": 0.6,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Strong analyst consensus with 60% Buy recommendations",
          "Positive news regarding potential earnings and stabilization in crypto markets",
          "High price target indicating confidence in future performance"
        ],
        "key_risks": [
          "Market volatility affecting stock performance",
          "Potential regulatory challenges in the crypto space",
          "Economic uncertainties that could impact banking sector"
        ],
        "price_target_upside": 0.6701234118681523
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.4896401847106334,
      "news_summary": "JPMorgan Chase & Co. is set to report its Q4 earnings on January 13, 2025, with analysts predicting an increase in earnings per share to $5.01 and revenue growth to $46.25 billion. The bank is also optimistic about easing outflows from cryptocurrency ETFs, indicating potential stabilization in the crypto market. Additionally, JPMorgan is expanding its blockchain initiatives, aiming to enhance its digital currency capabilities. Furthermore, Apple is transitioning its credit card services from Goldman Sachs to JPMorgan, which could impact customer engagement and revenue streams.",
      "price": 329.79,
      "market_cap": 897774.8264450487,
      "scored_at": "2026-01-09T06:21:05.015176"
    },
    {
      "ticker": "AAPL",
      "sector": "Information Technology",
      "theme": "Regulatory Changes Impacting Technology and Finance",
      "factor_scores": {
        "value": 0.03333333333333335,
        "quality": 1.0,
        "growth": 0.2,
        "stability": 0.5,
        "revisions": 0.5871794871794872,
        "momentum": -0.39297187277765494
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.7,
        "analyst_consensus": "Buy",
        "analyst_score": 0.6,
        "news_sentiment": "bullish",
        "news_score": 0.8,
        "key_drivers": [
          "Strong analyst consensus with 53.8% Buy recommendations",
          "Positive news from TSMC indicating strong demand in the semiconductor sector",
          "Bernstein's reiteration of a Buy rating on Apple Inc."
        ],
        "key_risks": [
          "Potential market volatility affecting tech stocks",
          "Dependence on supply chain stability for components",
          "Competition in the technology sector"
        ],
        "price_target_upside": 15.348980852378006
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.4673676397578405,
      "news_summary": "Apple Inc. (AAPL) continues to receive positive investment sentiment, with Bernstein reiterating a Buy rating and setting a price target of $325. The company benefits from its partnership with TSMC, which reported a 20% increase in fourth-quarter revenue, driven by strong demand for AI applications and semiconductor products. This trend is expected to bolster Apple's performance, particularly following the successful launch of the iPhone 17. Additionally, Bank of America Securities also reaffirmed a positive outlook for AAPL, indicating strong confidence in its market position.",
      "price": 259.04,
      "market_cap": 3827666.164288797,
      "scored_at": "2026-01-09T06:20:17.824079"
    },
    {
      "ticker": "ADBE",
      "sector": "Information Technology",
      "theme": null,
      "factor_scores": {
        "value": 0.6,
        "quality": 1.0,
        "growth": 0.5,
        "stability": 0.5,
        "revisions": 0.56875,
        "momentum": -0.26072173490671136
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.8,
        "analyst_consensus": "Buy",
        "analyst_score": 0.7,
        "news_sentiment": "bullish",
        "news_score": 0.9,
        "key_drivers": [
          "Strong analyst consensus with 56.2% Buy recommendations",
          "Positive news regarding partnerships and market growth",
          "Bullish sentiment from multiple news articles highlighting potential for rebound"
        ],
        "key_risks": [
          "Market volatility affecting tech stocks",
          "Potential competition in AI and digital tools",
          "Economic factors impacting e-commerce growth"
        ],
        "price_target_upside": -39.145823501651726
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.46079896500444234,
      "news_summary": "Adobe Inc. (ADBE) has recently garnered attention for its strategic partnership with Runway, enhancing its AI video tools, which positions it favorably in the growing AI market. Despite a challenging year with a 20.5% decline in total shareholder return, analysts suggest that ADBE may be undervalued compared to its SaaS peers, particularly with rising AI-driven annual recurring revenue (ARR) and ongoing buybacks. The stock is attracting renewed investor interest as it navigates a mixed performance landscape, indicating potential for recovery in 2026.",
      "price": 339.04,
      "market_cap": 141922.1486318419,
      "scored_at": "2026-01-09T06:23:28.506293"
    },
    {
      "ticker": "ISRG",
      "sector": "Health Care",
      "theme": null,
      "factor_scores": {
        "value": -0.16666666666666666,
        "quality": 0.7,
        "growth": 0.7,
        "stability": 0.5,
        "revisions": 0.5666666666666667,
        "momentum": 0.2754431810156089
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.5,
        "analyst_consensus": "Buy",
        "analyst_score": 0.5,
        "news_sentiment": "bullish",
        "news_score": 0.5,
        "key_drivers": [
          "Surging da Vinci usage and new FDA approvals",
          "Positive news regarding leadership changes",
          "Majority of analysts recommend a buy"
        ],
        "key_risks": [
          "Recent stock decline despite market gains",
          "Single bearish news headline",
          "Potential market volatility affecting performance"
        ],
        "price_target_upside": 7.366513980994036
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.4543861832229655,
      "news_summary": "Intuitive Surgical, Inc. (ISRG) recently experienced a slight decline, closing at $585.08, but has seen a significant 32% increase over the past three months, driven by strong demand for its da Vinci robotic systems and new FDA approvals expanding surgical applications. The stock is currently trading just 4% below its all-time high, reflecting positive investor sentiment amid rising procedure volumes and utilization rates. Analysts are closely monitoring the company's valuation as it continues to capitalize on the growing demand for minimally invasive surgical solutions. Overall, ISRG remains a trending stock with strong long-term performance indicators, including a 125.58% total shareholder return over five years.",
      "price": 585.08,
      "market_cap": 207408.56351531149,
      "scored_at": "2026-01-09T06:25:23.073874"
    },
    {
      "ticker": "JNJ",
      "sector": "Health Care",
      "theme": null,
      "factor_scores": {
        "value": 0.4666666666666667,
        "quality": 0.7,
        "growth": 0.0,
        "stability": 0.5,
        "revisions": 0.5615384615384615,
        "momentum": -0.048320850446967406
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.7,
        "analyst_consensus": "Hold",
        "analyst_score": 0.1,
        "news_sentiment": "bullish",
        "news_score": 0.8,
        "key_drivers": [
          "Recent agreements to cut drug prices, improving access to medicines.",
          "Positive government relations enhancing market position.",
          "Strong analyst recommendations leaning towards buy."
        ],
        "key_risks": [
          "Market volatility affecting stock performance.",
          "Potential regulatory changes impacting pricing strategies.",
          "Dependence on successful implementation of cost-cutting measures."
        ],
        "price_target_upside": 3.0716889428918557
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.45435346377602953,
      "news_summary": "Johnson & Johnson (JNJ) has reached a voluntary agreement with the Trump Administration to cut drug prices for Americans, which includes tariff exemptions for its pharmaceutical products. This move is expected to enhance access to medicines and lower costs for millions of patients. Additionally, JNJ is focusing on growth in its Innovative Medicine and MedTech segments to mitigate challenges from the Stelara patent cliff. Recent pipeline updates, including a Phase 2b win for nipocalimab and an FDA submission for the OTTAVA surgical system, indicate positive momentum for the company's future prospects.",
      "price": 205.75,
      "market_cap": 495712.4432989565,
      "scored_at": "2026-01-09T06:21:27.669025"
    },
    {
      "ticker": "NVDA",
      "sector": "Information Technology",
      "theme": "AI Infrastructure Buildout",
      "factor_scores": {
        "value": 0.03333333333333335,
        "quality": 1.0,
        "growth": 1.0,
        "stability": 0.0,
        "revisions": 0.9085106382978723,
        "momentum": -0.06523681858802537
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.8,
        "analyst_consensus": "Buy",
        "analyst_score": 0.8,
        "news_sentiment": "bullish",
        "news_score": 0.8,
        "key_drivers": [
          "Strong analyst consensus with 83% recommending Buy",
          "Positive news regarding partnerships in self-driving technology",
          "Strong revenue performance from TSMC indicating healthy semiconductor demand"
        ],
        "key_risks": [
          "Market volatility affecting tech stocks",
          "Potential supply chain disruptions",
          "Competition in AI and semiconductor sectors"
        ],
        "price_target_upside": -28.626242974492
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.4421484662543358,
      "news_summary": "Nvidia is actively pursuing partnerships with auto suppliers to advance its self-driving technology, despite challenges in safety and costs. Meanwhile, TSMC, Nvidia's primary chip supplier, reported a 20% revenue increase in Q4, driven by strong demand for AI applications, which bodes well for Nvidia's outlook. Citi has reiterated a Buy rating on Nvidia, setting a price target of $270, reflecting confidence in the company's growth potential in the AI sector. Additionally, Nvidia has appointed a new chief marketing officer from Google, aiming to enhance its market presence amid current stock performance challenges.",
      "price": 185.04,
      "market_cap": 4496472.014512788,
      "scored_at": "2026-01-09T06:20:53.495808"
    },
    {
      "ticker": "SYK",
      "sector": "Health Care",
      "theme": null,
      "factor_scores": {
        "value": -0.16666666666666666,
        "quality": 0.7,
        "growth": 0.5,
        "stability": 0.5,
        "revisions": 0.74,
        "momentum": 0.37319448791267046
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.5,
        "analyst_consensus": "Buy",
        "analyst_score": 0.64,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Strong buy recommendations from analysts (64%)",
          "Positive upgrade from Raymond James highlighting organic growth potential"
        ],
        "key_risks": [
          "Market skepticism despite reassurances on growth",
          "Concerns about valuation being largely priced in"
        ],
        "price_target_upside": 13.558998937937428
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.43745370577361925,
      "news_summary": "Stryker Corporation (SYK) recently received an upgrade from Raymond James to 'Outperform,' citing its strong track record of over 10% organic revenue growth and a favorable position in the medical technology sector. Following this upgrade, SYK shares rose by 4.1%, with a new price target set at $418. Despite these positive developments, some analysts express concerns about ongoing margin pressures and question whether the current valuation is justified given the company's growth rate. Overall, Stryker's consistent performance and market positioning continue to attract investor interest amid mixed market sentiment.",
      "price": 367.21,
      "market_cap": 140429.78668768934,
      "scored_at": "2026-01-09T06:25:28.873547"
    },
    {
      "ticker": "MSFT",
      "sector": "Information Technology",
      "theme": "Regulatory Changes Impacting Technology and Finance",
      "factor_scores": {
        "value": 0.13333333333333333,
        "quality": 1.0,
        "growth": 0.5,
        "stability": 0.5,
        "revisions": 0.9809523809523809,
        "momentum": -0.0949436885709164
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.9,
        "analyst_consensus": "Buy",
        "analyst_score": 0.88,
        "news_sentiment": "bullish",
        "news_score": 0.9,
        "key_drivers": [
          "Strong analyst consensus with 88.1% recommending 'Buy'",
          "Positive news regarding AI advancements and acquisitions",
          "High price target indicating significant upside potential"
        ],
        "key_risks": [
          "Market volatility affecting tech stocks",
          "Potential integration challenges with acquisitions",
          "Competition in the AI sector"
        ],
        "price_target_upside": -32.850180920708624
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.43334735269843705,
      "news_summary": "Microsoft (MSFT) recently announced the acquisition of Osmos, an AI data engineering platform, which is expected to enhance its capabilities in simplifying data workflows. Despite a slight decline in stock price, analysts remain optimistic, with Jefferies maintaining a Buy rating and a price target of $675, citing Microsoft's strong AI strategy as a long-term advantage. The broader market has shown mixed reactions to tech stocks, with investors becoming more selective in AI-related investments. As the company continues to innovate and expand its AI offerings, it is positioned to capitalize on the growing demand for AI technologies.",
      "price": 478.11,
      "market_cap": 3553493.9874824816,
      "scored_at": "2026-01-09T06:20:23.098900"
    },
    {
      "ticker": "CSCO",
      "sector": "Information Technology",
      "theme": null,
      "factor_scores": {
        "value": 0.3333333333333333,
        "quality": 0.7,
        "growth": 0.2,
        "stability": 0.5,
        "revisions": 0.6416666666666666,
        "momentum": -0.33212168419230687
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.5,
        "analyst_consensus": "Buy",
        "analyst_score": 0.5,
        "news_sentiment": "bullish",
        "news_score": 0.4,
        "key_drivers": [
          "Strong analyst consensus with 54.2% recommending a buy",
          "Positive news from related sectors indicating market confidence",
          "No sell recommendations indicating overall market support"
        ],
        "key_risks": [
          "Recent stock dip despite market gains could indicate underlying concerns",
          "Neutral news regarding potential acquisitions may signal indecision",
          "Market volatility affecting tech stocks could impact performance"
        ],
        "price_target_upside": 11.776636019469995
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.43259738011782656,
      "news_summary": "Cisco Systems (CSCO) has recently seen a slight decline in its stock price, closing at $73.96, down 1.02% amid broader market gains. Analysts from TD Cowen indicated that an acquisition of Axonius by Cisco is not imminent, which may impact investor sentiment. Despite a strong historical performance, with a 29.3% increase over the past year, the stock has faced a 3.0% drop in the last week and 5.2% over the past month, prompting discussions about its current valuation and long-term growth potential in the networking and security sectors.",
      "price": 73.96,
      "market_cap": 292222.9526942987,
      "scored_at": "2026-01-09T06:23:10.353089"
    },
    {
      "ticker": "AMGN",
      "sector": "Health Care",
      "theme": "Healthcare Innovation and Biotech Advancements",
      "factor_scores": {
        "value": 0.3666666666666667,
        "quality": 0.7,
        "growth": 0.7,
        "stability": 0.0,
        "revisions": 0.4939393939393939,
        "momentum": 0.07128817736498556
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.0,
        "analyst_consensus": "Hold",
        "analyst_score": 0.0,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Analyst consensus is predominantly Hold with a significant number of Buy recommendations.",
          "Price target indicates potential for upside from current price."
        ],
        "key_risks": [
          "Recent news includes bearish sentiment affecting stock performance.",
          "Market conditions appear challenging with stock falling despite overall market uptick."
        ],
        "price_target_upside": 9.624064705704154
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.4202777919957352,
      "news_summary": "Amgen (AMGN) experienced a decline of 3.39%, closing at $330.05 amid a broader market uptick. The company recently secured exclusive global rights from DISCO Pharmaceuticals for cancer therapies, potentially worth up to $618 million, enhancing its oncology portfolio. Additionally, Amgen's acquisition of Dark Blue Therapeutics for $840 million is expected to strengthen its early oncology pipeline. The company is set to present at the J.P. Morgan Healthcare Conference on January 12, 2026, which may provide further insights into its strategic direction.",
      "price": 330.11,
      "market_cap": 177757.87575415763,
      "scored_at": "2026-01-09T06:24:59.572978"
    },
    {
      "ticker": "VZ",
      "sector": "Communication Services",
      "theme": null,
      "factor_scores": {
        "value": 0.8,
        "quality": 0.5,
        "growth": 0.0,
        "stability": 0.5,
        "revisions": 0.43333333333333335,
        "momentum": -0.032735903101726124
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.4,
        "analyst_consensus": "Hold",
        "analyst_score": 0.2,
        "news_sentiment": "bullish",
        "news_score": 0.4,
        "key_drivers": [
          "Recent positive performance in the stock market",
          "Bullish sentiment in recent news articles",
          "Strong dividend yield potential"
        ],
        "key_risks": [
          "Concerns over competition in the telecom sector",
          "Potential impact of wireless price wars",
          "Limited technical indicators available for analysis"
        ],
        "price_target_upside": 15.849149617944294
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.41590146493166386,
      "news_summary": "Verizon Communications (VZ) saw a slight increase in its stock price, closing at $40.57, amid growing concerns over a potential wireless price war with competitors AT&T and T-Mobile. The company is actively engaging customers through high-profile events like the Super Bowl and FIFA World Cup, showcasing its Industrial IoT capabilities at CES 2026. However, T-Mobile has recently outperformed Verizon and AT&T in key network rankings, raising questions about Verizon's competitive position in the market. Investors should monitor these developments as they may impact Verizon's market share and growth prospects.",
      "price": 40.57,
      "market_cap": 171060.37868828056,
      "scored_at": "2026-01-09T06:22:45.790000"
    },
    {
      "ticker": "MCD",
      "sector": "Consumer Discretionary",
      "theme": null,
      "factor_scores": {
        "value": 0.3333333333333333,
        "quality": 0.85,
        "growth": 0.0,
        "stability": 0.5,
        "revisions": 0.49473684210526314,
        "momentum": 0.08861477385509713
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.1,
        "analyst_consensus": "Hold",
        "analyst_score": 0.1,
        "news_sentiment": "bullish",
        "news_score": 0.3,
        "key_drivers": [
          "Analysts are reassessing pricing upside, indicating potential for growth.",
          "Recent bullish news headlines suggest positive market sentiment."
        ],
        "key_risks": [
          "High percentage of Hold recommendations may indicate uncertainty.",
          "Concerns over rising beef costs could impact margins."
        ],
        "price_target_upside": 8.187645687645695
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.3791153233999503,
      "news_summary": "McDonald's (MCD) is currently in the spotlight due to a high-profile McRib class action lawsuit and new family-oriented promotions, including a Crayola partnership and a Pokémon Happy Meal campaign set for 2026. Analysts remain cautiously optimistic, with approximately 45% maintaining a bullish outlook and a median price target of $340, suggesting a potential upside of 13.4%. Despite recent fluctuations, including a slight decline in share price over the past month, the stock has shown steady long-term performance with a 1-year return of 8.49%. Additionally, movements in the options market indicate heightened investor interest, warranting close attention to MCD's stock.",
      "price": 308.88,
      "market_cap": 219970.240719808,
      "scored_at": "2026-01-09T06:24:44.486379"
    },
    {
      "ticker": "KO",
      "sector": "Consumer Staples",
      "theme": null,
      "factor_scores": {
        "value": 0.13333333333333333,
        "quality": 0.7,
        "growth": 0.0,
        "stability": 0.0,
        "revisions": 0.9461538461538461,
        "momentum": -0.06436847375196587
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.7,
        "analyst_consensus": "Buy",
        "analyst_score": 0.8,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Strong analyst consensus with 84.6% recommending Buy",
          "Inclusion in Wells Fargo's Q1 2026 Tactical Ideas List",
          "Recognition as a top dividend aristocrat for 2026"
        ],
        "key_risks": [
          "Market volatility affecting consumer goods",
          "Potential regulatory changes impacting tariffs",
          "Economic downturn affecting beverage sales"
        ],
        "price_target_upside": 13.882081591466044
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.3791082167566219,
      "news_summary": "Coca-Cola (NYSE: KO) has been added to Wells Fargo's Q1 2026 Tactical Ideas List, highlighting its favorable positioning for the upcoming year. The stock continues to be recognized as a reliable dividend aristocrat, attracting investor attention amid discussions about its long-term payout reliability. CEO James Quincey's recent interview emphasizes the company's commitment to balancing tradition with innovation as it navigates market changes. Overall, KO remains a focal point for investors looking for stable dividend stocks in 2026.",
      "price": 69.37,
      "market_cap": 298402.61251639604,
      "scored_at": "2026-01-09T06:22:01.967353"
    },
    {
      "ticker": "HD",
      "sector": "Consumer Discretionary",
      "theme": "Labor Market Dynamics and Wage Growth",
      "factor_scores": {
        "value": 0.13333333333333333,
        "quality": 0.7,
        "growth": 0.0,
        "stability": 0.0,
        "revisions": 0.6714285714285714,
        "momentum": 0.37440666472924483
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.7,
        "analyst_consensus": "Buy",
        "analyst_score": 0.7,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Strong analyst consensus with 57.1% recommending 'Buy'",
          "Positive news coverage highlighting Home Depot as a preferred investment",
          "Overall bullish sentiment in the housing market despite current challenges"
        ],
        "key_risks": [
          "Potential impact of lower interest rates not stimulating the housing market",
          "Market volatility affecting consumer spending on home improvement",
          "Economic uncertainties that could impact housing demand"
        ],
        "price_target_upside": 12.876849482701083
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.37383795909141526,
      "news_summary": "Home Depot (HD) is gaining attention as a potential beneficiary of a shift in investor sentiment towards cash-rich retailers amid easing Federal Reserve interest rates. Analysts note that high home prices and mortgage costs are prompting homeowners to invest in renovations rather than moving, which could bolster demand for Home Depot's products. The stock recently closed at $349.29, reflecting a 1.51% increase, indicating positive market momentum. Additionally, Jim Cramer has expressed a preference for Home Depot over competitors like Fortune Brands, further highlighting its strong position in the housing market.",
      "price": 359.56,
      "market_cap": 357946.1033072976,
      "scored_at": "2026-01-09T06:22:22.849926"
    },
    {
      "ticker": "MDT",
      "sector": "Health Care",
      "theme": null,
      "factor_scores": {
        "value": 0.5,
        "quality": 0.35,
        "growth": 0.0,
        "stability": 0.5,
        "revisions": 0.5193548387096774,
        "momentum": 0.22815601360260906
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Hold",
        "analyst_score": 0.2,
        "news_sentiment": "bullish",
        "news_score": 0.5,
        "key_drivers": [
          "Positive study results for MiniMed™ 780G system",
          "Recent upgrade from William Blair",
          "Strong performance in achieving ADA-recommended goals"
        ],
        "key_risks": [
          "High percentage of Hold recommendations",
          "Limited technical indicators available",
          "Market volatility affecting stock performance"
        ],
        "price_target_upside": 13.040834937683659
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.37223169957247443,
      "news_summary": "Medtronic (MDT) has recently gained attention following an upgrade to 'Outperform' by William Blair, which highlights the positive impact of FDA approvals for its Hugo surgical system and the Symplicity Spyral device. The stock has shown a short-term upward trend, with a 3.03% increase in one day and a 3.78% rise over the past week. Additionally, a study on the MiniMed™ 780G system demonstrated its effectiveness in achieving ADA-recommended time-in-range goals, further supporting Medtronic's position in the diabetes management market. Despite a recent share price pullback, MDT has delivered a 25.7% return over the past year, indicating potential value for investors.",
      "price": 98.69,
      "market_cap": 126521.98525578291,
      "scored_at": "2026-01-09T06:25:40.317124"
    },
    {
      "ticker": "NOW",
      "sector": "Information Technology",
      "theme": null,
      "factor_scores": {
        "value": -0.06666666666666665,
        "quality": 0.2,
        "growth": 1.0,
        "stability": 0.0,
        "revisions": 0.9333333333333333,
        "momentum": -0.3807907391692234
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.5,
        "analyst_consensus": "Buy",
        "analyst_score": 0.7,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Strong analyst consensus with 86.1% recommending Buy",
          "Jefferies' bullish outlook on AI growth potential",
          "Potential for recovery after recent share price weakness"
        ],
        "key_risks": [
          "High price-to-earnings multiple noted by Jim Cramer",
          "Only 2.8% of analysts recommending Sell indicates some skepticism",
          "Mixed news sentiment with some bearish commentary"
        ],
        "price_target_upside": 9.811888638073736
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.36758139337289414,
      "news_summary": "ServiceNow (NOW) has experienced a notable decline in its stock price, closing at $150.90, reflecting an 11.6% drop over the past month and a 28.1% decline year-over-year. Despite this, analysts from Jefferies and Canaccord Genuity have reaffirmed a bullish outlook, with Jefferies naming it a top AI growth stock and Canaccord setting a price target of $224.00. The company is set to announce its fourth-quarter and full-year financial results on January 28, 2026, which could provide further insights into its performance amidst mixed market sentiments. Additionally, Jim Cramer has expressed concerns about its high price-to-earnings multiple in the current market environment.",
      "price": 146.19,
      "market_cap": 151802.33717412222,
      "scored_at": "2026-01-09T06:23:41.558533"
    },
    {
      "ticker": "META",
      "sector": "Communication Services",
      "theme": null,
      "factor_scores": {
        "value": 0.4666666666666667,
        "quality": 1.0,
        "growth": 1.0,
        "stability": 0.5,
        "revisions": 0.6,
        "momentum": -0.17712231160397426
      },
      "sentiment": {
        "overall_sentiment": "bearish",
        "sentiment_score": -0.4,
        "analyst_consensus": "Buy",
        "analyst_score": 0.5,
        "news_sentiment": "bearish",
        "news_score": -0.5,
        "key_drivers": [
          "Analyst consensus remains a strong Buy despite mixed recommendations.",
          "Price target suggests significant upside potential."
        ],
        "key_risks": [
          "Recent downgrade by Goldman Sachs raises concerns.",
          "Negative news regarding employee dissatisfaction could impact morale and performance."
        ],
        "price_target_upside": -45.825465127077976
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.3661687788125091,
      "news_summary": "Recent reports indicate that Alexandr Wang, Meta's highest-paid employee, is feeling 'suffocated' due to the micromanagement style of CEO Mark Zuckerberg. This dissatisfaction could signal potential challenges in leadership dynamics within the company, which may affect employee morale and productivity. Investors should monitor how this internal strife might influence Meta's operational efficiency and overall corporate culture moving forward.",
      "price": 646.06,
      "market_cap": 1628411.995127199,
      "scored_at": "2026-01-09T06:20:40.803068"
    },
    {
      "ticker": "COIN",
      "sector": "Financials",
      "theme": "Regulatory Changes Impacting Technology and Finance",
      "factor_scores": {
        "value": 0.4666666666666667,
        "quality": 0.5,
        "growth": 1.0,
        "stability": 0.5,
        "revisions": 0.6483870967741935,
        "momentum": 0.716738893310929
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.1,
        "analyst_consensus": "Buy",
        "analyst_score": 0.4,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Majority of analysts recommend a Buy",
          "Positive long-term outlook from BofA regarding Coinbase"
        ],
        "key_risks": [
          "Recent downgrade by BofA",
          "Mixed news sentiment with bearish headlines"
        ],
        "price_target_upside": -26.198135103220814
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.3657228454059992,
      "news_summary": "Coinbase (COIN) received an upgrade to 'Buy' from Bank of America, which cited the company's product expansion and favorable valuation as key factors for potential growth in 2026. Despite this positive outlook, COIN's stock experienced a slight decline of 1.71% recently, closing at $250.56. The broader cryptocurrency market is showing signs of recovery, with Bitcoin stabilizing above $91,000 after a tumultuous period, which may positively influence Coinbase's performance. Additionally, the competitive landscape is shifting, as Goldman Sachs upgraded Coinbase while downgrading eToro, highlighting the evolving dynamics in the trading and crypto sectors.",
      "price": 245.59,
      "market_cap": 66225.14784973,
      "scored_at": "2026-01-09T06:27:07.953644"
    },
    {
      "ticker": "ZTS",
      "sector": "Health Care",
      "theme": null,
      "factor_scores": {
        "value": 0.23333333333333334,
        "quality": 1.0,
        "growth": 0.2,
        "stability": 0.5,
        "revisions": 0.7111111111111111,
        "momentum": 0.06821914904890593
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.7,
        "analyst_consensus": "Buy",
        "analyst_score": 0.6,
        "news_sentiment": "bullish",
        "news_score": 0.5,
        "key_drivers": [
          "Strong analyst consensus with 61.1% recommending 'Buy'",
          "Positive news highlighting Zoetis as a high-quality dividend growth stock",
          "Strategic positioning in the veterinary diagnostics market"
        ],
        "key_risks": [
          "Market competition from other veterinary companies",
          "Potential economic downturn affecting consumer spending on pet care",
          "Regulatory challenges in the veterinary industry"
        ],
        "price_target_upside": -37.65471028774143
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.34875117640973624,
      "news_summary": "Zoetis Inc. (ZTS) has faced significant share price declines, with a 19.8% drop over the past year and a sell rating from analysts due to slowing growth and lowered guidance. Despite recent outperformance on a strong trading day, concerns about its valuation persist, with an EV/FCF ratio near 25x. Notably, investment strategist Stephanie Link has increased her holdings in Zoetis, indicating potential confidence in the stock amidst its current challenges. The veterinary diagnostics market is expected to grow, which could benefit Zoetis in the long term.",
      "price": 126.85,
      "market_cap": 56897.89778056041,
      "scored_at": "2026-01-09T06:25:35.336003"
    },
    {
      "ticker": "PG",
      "sector": "Consumer Staples",
      "theme": null,
      "factor_scores": {
        "value": 0.2333333333333333,
        "quality": 0.85,
        "growth": 0.0,
        "stability": 0.0,
        "revisions": 0.6555555555555556,
        "momentum": -0.10350522178028988
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.3,
        "analyst_consensus": "Buy",
        "analyst_score": 0.5,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Strong analyst consensus with 55.6% Buy recommendations",
          "Positive sentiment in consumer stocks sector",
          "Procter & Gamble's wide moat and solid business fundamentals"
        ],
        "key_risks": [
          "Concerns over legal scrutiny and new CEO's focus on pricing",
          "Bearish outlook from some analysts regarding valuation",
          "Wells Fargo's target trim indicating potential headwinds"
        ],
        "price_target_upside": 16.462940719282138
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.34718758203162636,
      "news_summary": "Procter & Gamble (PG) has recently faced challenges, including legal scrutiny over some of its products and a decline in demand, leading to a 52-week low in its stock price. Despite reporting revenue and EPS growth in Q1, analysts express concerns about its valuation, prompting Wells Fargo to lower its price target from $170 to $158 while maintaining an Overweight rating. The company is also navigating complex markets and preparing for an earnings call under new CEO Shailesh Jejurikar, which may influence its pricing strategy moving forward. Overall, while PG remains a strong brand with a solid dividend yield, near-term pressures could impact investor sentiment.",
      "price": 141.53,
      "market_cap": 330717.8617959067,
      "scored_at": "2026-01-09T06:21:57.346292"
    },
    {
      "ticker": "LULU",
      "sector": "Consumer Discretionary",
      "theme": null,
      "factor_scores": {
        "value": 0.13333333333333333,
        "quality": 1.0,
        "growth": 0.5,
        "stability": 0.5,
        "revisions": 0.1606060606060606,
        "momentum": 0.17483919606050338
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.1,
        "analyst_consensus": "Hold",
        "analyst_score": 0.1,
        "news_sentiment": "bullish",
        "news_score": 0.3,
        "key_drivers": [
          "Bullish outlook from Deutsche Bank on retail sector",
          "Recent acquisition by Centric Brands may enhance product offerings"
        ],
        "key_risks": [
          "Boardroom challenge could create uncertainty",
          "Global trade policy risks affecting supply chain"
        ],
        "price_target_upside": -5.123250223877069
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.34667069338357764,
      "news_summary": "Lululemon athletica (LULU) is currently navigating a leadership transition as founder Chip Wilson challenges the board by nominating three independent director candidates amid an ongoing CEO search. Despite this internal turmoil, the company has reported a 10.95% return over the past 30 days and a 21.74% return over the last 90 days, although it has experienced a significant 46.67% decline in total shareholder return over the past year. Additionally, trade policy risks are prompting LULU to consider diversifying its supply chain to mitigate rising costs. Overall, the retail sector outlook for 2026 appears positive, which may benefit LULU as consumer conditions improve.",
      "price": 212.17,
      "market_cap": 25974.2845015828,
      "scored_at": "2026-01-09T06:24:37.801313"
    },
    {
      "ticker": "NFLX",
      "sector": "Communication Services",
      "theme": null,
      "factor_scores": {
        "value": 0.16666666666666666,
        "quality": 1.0,
        "growth": 0.7,
        "stability": 0.5,
        "revisions": 0.6945945945945945,
        "momentum": -0.2870804891922643
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.1,
        "analyst_consensus": "Buy",
        "analyst_score": 0.5,
        "news_sentiment": "bearish",
        "news_score": -0.3,
        "key_drivers": [
          "Majority of analysts recommend 'Buy'",
          "Price target suggests potential for growth"
        ],
        "key_risks": [
          "Recent downgrade from CFRA to 'Hold'",
          "Significant stock loss of 12.9% in December 2025"
        ],
        "price_target_upside": -26.941345410361205
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.32708454126969483,
      "news_summary": "Netflix (NFLX) has recently faced a downgrade from CFRA, reducing its price target from $130 to $100, primarily due to its pending acquisition of Warner Bros Discovery, which has contributed to a nearly 13% stock drop in December. Despite this, Netflix is working to improve its relationship with AMC Theaters, which could enhance its market position. The company also completed a 10-for-1 stock split in November, attracting mixed investor sentiment as it navigates these challenges. Overall, the market remains cautious as Netflix's strategic moves unfold amid competitive pressures.",
      "price": 90.53,
      "market_cap": 413676.40826474887,
      "scored_at": "2026-01-09T06:22:33.972002"
    },
    {
      "ticker": "PEP",
      "sector": "Consumer Staples",
      "theme": null,
      "factor_scores": {
        "value": 0.26666666666666666,
        "quality": 0.55,
        "growth": 0.0,
        "stability": 0.5,
        "revisions": 0.4076923076923077,
        "momentum": -0.24096525455221138
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.4,
        "analyst_consensus": "Hold",
        "analyst_score": 0.2,
        "news_sentiment": "bullish",
        "news_score": 0.4,
        "key_drivers": [
          "Positive news regarding partnerships with Siemens and NVIDIA",
          "Bullish sentiment from multiple dividend stock recommendations",
          "Support for social causes like ending student hunger"
        ],
        "key_risks": [
          "Potential negative impact from Supreme Court decisions on tariffs",
          "Market volatility affecting consumer goods sector",
          "High valuation concerns amidst economic uncertainty"
        ],
        "price_target_upside": 13.604075482528527
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.31386123940471766,
      "news_summary": "PepsiCo (PEP) has announced a significant multi-year partnership with Siemens and NVIDIA to implement AI and digital twin technology across its operations, aiming to enhance efficiency and reduce capital expenditures. Despite this strategic move, PEP's stock has experienced a decline, with a 4.54% drop over the past week and a modest 2.77% total return over the past year. This collaboration positions PepsiCo as a leader in adopting advanced industrial technologies within the consumer packaged goods sector, potentially impacting its operational performance and investor sentiment moving forward.",
      "price": 139.37,
      "market_cap": 190566.18040904656,
      "scored_at": "2026-01-09T06:22:07.124642"
    },
    {
      "ticker": "LOW",
      "sector": "Consumer Discretionary",
      "theme": null,
      "factor_scores": {
        "value": 0.26666666666666666,
        "quality": 0.7,
        "growth": -0.5,
        "stability": 0.0,
        "revisions": 0.6161290322580645,
        "momentum": 0.5200558412119195
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.7,
        "analyst_consensus": "Buy",
        "analyst_score": 0.7,
        "news_sentiment": "bullish",
        "news_score": 0.8,
        "key_drivers": [
          "Strong analyst consensus with 54.8% Buy recommendations",
          "Positive news sentiment with multiple bullish headlines",
          "Optimism in the housing market and consumer spending"
        ],
        "key_risks": [
          "Potential market volatility affecting consumer spending",
          "Mixed signals in consumer spending trends",
          "Limited technical indicators for further analysis"
        ],
        "price_target_upside": 7.568010616291342
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.30566574154260545,
      "news_summary": "Lowe's Companies (LOW) has recently received an upgrade from Barclays to overweight, reflecting optimism about the home improvement retailer's potential benefits from an improving housing market and pent-up demand. The stock has shown modest momentum with a 90-day return of 5.31% and a 1-year total shareholder return of 2.10%. Additionally, Lowe's is recognized as a reliable dividend payer, included among the best dividend growth stocks for 2026, with a payout ratio of approximately 40%. Overall, the recent analyst upgrades and stable demand position Lowe's favorably in the current market environment.",
      "price": 256.21,
      "market_cap": 143721.35945783943,
      "scored_at": "2026-01-09T06:22:28.845801"
    },
    {
      "ticker": "XOM",
      "sector": "Energy",
      "theme": null,
      "factor_scores": {
        "value": 0.5666666666666667,
        "quality": 0.2,
        "growth": 0.0,
        "stability": 0.0,
        "revisions": 0.5615384615384615,
        "momentum": 0.17796797961331734
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Hold",
        "analyst_score": 0.1,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Positive news regarding Exxon Mobil's extended buy time",
          "Increased demand for LNG as indicated by Venture Global's performance",
          "Strategic meetings involving US oil majors and Venezuela's energy sector"
        ],
        "key_risks": [
          "Market uncertainty surrounding geopolitical developments in Venezuela",
          "Potential regulatory changes affecting oil majors",
          "Fluctuations in global oil prices"
        ],
        "price_target_upside": 15.710682613294283
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.30322436044556694,
      "news_summary": "ExxonMobil is actively participating in discussions with the White House and other major oil companies regarding potential investments to revitalize Venezuela's struggling energy sector. The company, which previously exited Venezuela due to nationalization policies, is now considering re-entering the market amidst rising oil prices and increased demand. Analysts are optimistic about XOM stock, suggesting it remains a strong buy as energy stocks gain traction in the current market environment. However, challenges remain due to Venezuela's severely degraded oil infrastructure and production capabilities.",
      "price": 122.91,
      "market_cap": 506987.6305567703,
      "scored_at": "2026-01-09T06:21:44.696064"
    },
    {
      "ticker": "UNH",
      "sector": "Health Care",
      "theme": null,
      "factor_scores": {
        "value": -0.09999999999999999,
        "quality": 0.2,
        "growth": 0.2,
        "stability": 0.5,
        "revisions": 0.676923076923077,
        "momentum": 0.4225864105904094
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.7,
        "analyst_consensus": "Buy",
        "analyst_score": 0.7,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Analysts have a strong buy consensus with 61.5% recommending buy.",
          "Positive news coverage highlighting UnitedHealth's market performance and future potential.",
          "Recent price target increases from analysts indicating confidence in the stock's growth."
        ],
        "key_risks": [
          "Market volatility could impact stock performance.",
          "Potential regulatory changes affecting the healthcare sector.",
          "Economic factors that could influence investor sentiment."
        ],
        "price_target_upside": 12.18970736629666
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.2988777411636459,
      "news_summary": "UnitedHealth Group (NYSE:UNH) has recently seen positive analyst sentiment, with Bernstein raising its price target to $444 and Barclays increasing its target to $391, both maintaining favorable ratings. The stock has outperformed market gains, closing at $346.85, and is recognized as a top investment choice for 2026 amid expectations of margin recovery in managed care. Analysts are optimistic about UNH's revenue prospects and operational recovery, suggesting a potential turnaround following a challenging 2025. Overall, renewed confidence from analysts highlights UNH's strong position in the insurance market.",
      "price": 346.85,
      "market_cap": 314190.13762835256,
      "scored_at": "2026-01-09T06:21:21.715878"
    },
    {
      "ticker": "GILD",
      "sector": "Health Care",
      "theme": null,
      "factor_scores": {
        "value": -0.06666666666666665,
        "quality": 0.35,
        "growth": 0.2,
        "stability": 0.0,
        "revisions": 0.8037037037037037,
        "momentum": -0.14054098093530995
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.7,
        "analyst_consensus": "Buy",
        "analyst_score": 0.7,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Strong analyst consensus with 70.4% recommending a buy",
          "Positive news regarding collaborations and clinical trials",
          "Upcoming milestones highlighted by Xilio Therapeutics"
        ],
        "key_risks": [
          "Market volatility affecting share price momentum",
          "Potential competition in the oncology pipeline",
          "Regulatory challenges in drug approvals"
        ],
        "price_target_upside": 10.748321869561602
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.27858094094311575,
      "news_summary": "Gilead Sciences (GILD) has experienced mixed stock performance recently, with a slight decline of 2.71% in the latest trading session, despite a 37.65% total shareholder return over the past year. The company is actively involved in collaborations, including a new partnership with OncoNano Medicine to explore drug delivery technologies. Additionally, Gilead is part of the growing TIGIT inhibitors market, which is expected to expand significantly by 2030, indicating potential future growth opportunities. Overall, Gilead's stock has shown a flat year-to-date performance, aligning closely with broader market trends.",
      "price": 120.67,
      "market_cap": 149712.80132324537,
      "scored_at": "2026-01-09T06:25:05.603171"
    },
    {
      "ticker": "HON",
      "sector": "Industrials",
      "theme": "Geopolitical Risk and Supply Chain Resilience",
      "factor_scores": {
        "value": 0.13333333333333333,
        "quality": 0.5,
        "growth": 0.2,
        "stability": 0.0,
        "revisions": 0.6161290322580645,
        "momentum": 0.4335605788781249
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.0,
        "analyst_consensus": "Buy",
        "analyst_score": 0.5,
        "news_sentiment": "bearish",
        "news_score": -0.5,
        "key_drivers": [
          "Strong analyst consensus with 54.8% Buy recommendations",
          "Positive sentiment from defense spending plans indicating potential demand"
        ],
        "key_risks": [
          "Bearish news headlines indicating industry headwinds",
          "Recent price target trim by analysts"
        ],
        "price_target_upside": 15.279672578444739
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.2618643798441708,
      "news_summary": "Honeywell International Inc. (NASDAQ:HON) has seen its price target lowered by Mizuho from $250 to $240, reflecting concerns over an uneven industry backdrop despite maintaining an Outperform rating. The company's aerospace segment is experiencing strong growth driven by increased aftermarket demand and defense spending, which may help offset challenges in manufacturing and supply chain. Additionally, Honeywell is highlighted as a key player in the diversified operations sector, alongside 3M, as they navigate current market headwinds.",
      "price": 205.24,
      "market_cap": 130304.24678311807,
      "scored_at": "2026-01-09T06:27:00.547449"
    },
    {
      "ticker": "DHR",
      "sector": "Health Care",
      "theme": null,
      "factor_scores": {
        "value": -0.06666666666666665,
        "quality": 0.5,
        "growth": -0.5,
        "stability": 0.5,
        "revisions": 0.8894736842105263,
        "momentum": 0.22132913972858104
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.7,
        "analyst_consensus": "Buy",
        "analyst_score": 0.7,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Strong analyst consensus with 78.9% recommending a Buy",
          "Positive news articles highlighting recovery and market opportunities",
          "Leading position in the microtome market with significant market share"
        ],
        "key_risks": [
          "Concerns about potential overvaluation after steady share performance",
          "Neutral sentiment in some recent news indicating uncertainty",
          "Market volatility affecting overall stock performance"
        ],
        "price_target_upside": 6.808510638297872
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.2539814210229984,
      "news_summary": "Danaher Corporation (DHR) is poised for recovery as it navigates post-COVID challenges, with finalized tariff rules and depleted inventories. The company is a leader in the microtome market, which is expected to grow due to increased demand for disease diagnosis and drug discovery. Analysts are cautiously optimistic ahead of Danaher's upcoming fourth-quarter earnings report, with expectations for stable bottom-line performance year-over-year. Despite recent share price momentum, the stock has shown mixed performance over the past year, prompting discussions about its valuation and growth prospects.",
      "price": 235.0,
      "market_cap": 165992.14902092796,
      "scored_at": "2026-01-09T06:25:48.271629"
    },
    {
      "ticker": "WMT",
      "sector": "Consumer Staples",
      "theme": "Labor Market Dynamics and Wage Growth",
      "factor_scores": {
        "value": -0.39999999999999997,
        "quality": 0.05000000000000002,
        "growth": 0.2,
        "stability": 0.5,
        "revisions": 1.0,
        "momentum": 0.12416599347754514
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.9,
        "analyst_consensus": "Buy",
        "analyst_score": 0.9,
        "news_sentiment": "bullish",
        "news_score": 0.9,
        "key_drivers": [
          "Strong analyst consensus with 93.9% recommending a buy",
          "Positive news regarding Walmart's digital health initiatives",
          "Bullish sentiment around holiday sales and dividend attractiveness"
        ],
        "key_risks": [
          "Potential market volatility affecting stock performance",
          "Economic conditions impacting consumer spending",
          "Competition from other retail giants like Costco"
        ],
        "price_target_upside": 11.14353940037146
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.2511507615941688,
      "news_summary": "Walmart (WMT) is making significant strides in the digital health sector with the launch of its Better Care Services platform, which connects customers to various healthcare providers and offers wellness products at reduced prices. The company has also welcomed tech leader Shishir Mehrotra to its board, enhancing its focus on technology and health initiatives. Analysts are optimistic about Walmart's prospects, with Mizuho raising its price target to $125 and highlighting it as one of the best Dow stocks for 2026. Additionally, Walmart's strong performance is reflected in its recent share price growth, with a 90-day return of 10.76% and a one-year total shareholder return of 23.96%.",
      "price": 113.07,
      "market_cap": 901186.7915664765,
      "scored_at": "2026-01-09T06:22:12.380097"
    },
    {
      "ticker": "AMZN",
      "sector": "Consumer Discretionary",
      "theme": "Labor Market Dynamics and Wage Growth",
      "factor_scores": {
        "value": -0.09999999999999999,
        "quality": 0.4,
        "growth": 0.5,
        "stability": 0.5,
        "revisions": 1.0,
        "momentum": 0.5585160153655085
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.7,
        "analyst_consensus": "Buy",
        "analyst_score": 0.8,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Strong analyst consensus with 92.9% recommending Buy",
          "Positive news sentiment with multiple bullish headlines",
          "Strategic positioning in AI market"
        ],
        "key_risks": [
          "Market volatility affecting stock performance",
          "Potential competition in AI and e-commerce sectors",
          "Economic uncertainties impacting consumer spending"
        ],
        "price_target_upside": -39.69710503877542
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.2504055245412146,
      "news_summary": "Amazon (AMZN) has recently gained approximately 6% in value, outperforming the S&P 500, which may indicate positive momentum as the company positions itself as a leader in artificial intelligence. Analysts have noted that while Amazon's modeled fair value remains relatively stable, discussions around AI infrastructure and advertising growth are countered by concerns over capital spending and cloud economics. Jim Cramer has expressed that Amazon's previous underperformance was unwarranted, suggesting a potential for recovery. Overall, the stock's recent performance and strategic focus on AI could be significant for investors looking ahead to 2026.",
      "price": 246.29,
      "market_cap": 2632893.227775038,
      "scored_at": "2026-01-09T06:20:29.775241"
    },
    {
      "ticker": "BIIB",
      "sector": "Health Care",
      "theme": null,
      "factor_scores": {
        "value": 0.7999999999999999,
        "quality": 0.5,
        "growth": -0.5,
        "stability": 0.5,
        "revisions": 0.40303030303030296,
        "momentum": 0.47398526431425986
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.1,
        "analyst_consensus": "Hold",
        "analyst_score": 0.1,
        "news_sentiment": "bullish",
        "news_score": 0.2,
        "key_drivers": [
          "Acceptance of Biologics License Application for LEQEMBI in China",
          "Positive implications of at-home LEQEMBI injections for shareholders"
        ],
        "key_risks": [
          "General market downturn affecting biotech and pharma stocks",
          "Limited analyst buy recommendations indicating caution"
        ],
        "price_target_upside": -2.6881720430107525
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.24784652634145546,
      "news_summary": "Biogen (BIIB) and Eisai have received acceptance from Chinese regulators for a Biologics License Application for a subcutaneous, at-home version of their Alzheimer's drug LEQEMBI, which could enhance patient access and alleviate healthcare system pressures in China. This development comes as Biogen's stock has shown a 15.67% return over the past 90 days, contrasting with a flat year-to-date performance. Additionally, mixed analyst opinions are emerging regarding Biogen's future earnings potential, particularly in light of new data on its ALS therapy QALSODY and its recent removal from the Nasdaq-100 index.",
      "price": 186.0,
      "market_cap": 27286.62284922155,
      "scored_at": "2026-01-09T06:25:11.734186"
    },
    {
      "ticker": "CAT",
      "sector": "Industrials",
      "theme": "Infrastructure Spending Surge",
      "factor_scores": {
        "value": 0.5,
        "quality": 0.7,
        "growth": -0.5,
        "stability": 0.5,
        "revisions": 0.42000000000000004,
        "momentum": 0.5129145064907104
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.4,
        "analyst_consensus": "Hold",
        "analyst_score": 0.2,
        "news_sentiment": "bullish",
        "news_score": 0.4,
        "key_drivers": [
          "Positive analyst reports highlighting Caterpillar's potential",
          "Innovations in AI and autonomy for construction sites",
          "Strong insider ownership indicating confidence in the company"
        ],
        "key_risks": [
          "Concerns over potential tariffs impacting business",
          "Market volatility affecting stock performance",
          "Limited sell recommendations indicating caution among analysts"
        ],
        "price_target_upside": -5.612286846562412
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.22895236989836884,
      "news_summary": "Caterpillar (CAT) is advancing its technology by integrating AI and autonomy into its construction machinery, in partnership with Nvidia, aiming to enhance efficiency on job sites. This move aligns with broader trends in the construction industry towards automation and smart technology. Additionally, insider ownership remains significant, with Caxton and CTP Publishers and Printers holding a 47% stake, indicating strong vested interests in the company's performance. As the market navigates uncertainties, including potential tariff implications, CAT's innovations may position it favorably for future growth.",
      "price": 608.13,
      "market_cap": 284592.43357812025,
      "scored_at": "2026-01-09T06:24:11.147851"
    },
    {
      "ticker": "NEE",
      "sector": "Utilities",
      "theme": "Energy Transition and Sustainability",
      "factor_scores": {
        "value": 0.36666666666666664,
        "quality": 0.25,
        "growth": -0.5,
        "stability": 0.5,
        "revisions": 0.6833333333333333,
        "momentum": -0.08200465039030126
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Buy",
        "analyst_score": 0.7,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Strong analyst consensus with 62.5% recommending Buy",
          "Positive news highlighting NextEra Energy's performance and dividend potential",
          "Current trading above 200-day SMA indicating bullish momentum"
        ],
        "key_risks": [
          "Recent dip in stock price compared to broader market",
          "Concerns raised in neutral news regarding utilities sector",
          "Only one Sell recommendation indicating some skepticism"
        ],
        "price_target_upside": 12.97018492892188
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.22863469918776344,
      "news_summary": "NextEra Energy (NEE) is currently trading at approximately $78.37, reflecting a 3.31% decline from the previous close, and has seen a 2.4% drop over the past week and a 3.2% decline year-to-date. Despite these recent downturns, the stock has gained 14.4% over the past year, supported by strong clean energy investments and rising demand. Analysts generally recommend adding NEE to portfolios, although there are concerns about whether the stock's current price reflects its growth potential. Overall, NEE remains a solid option for investors seeking income and exposure to the growing clean energy sector.",
      "price": 79.49,
      "market_cap": 165546.6444271823,
      "scored_at": "2026-01-09T06:26:05.173129"
    },
    {
      "ticker": "PLNT",
      "sector": "Consumer Discretionary",
      "theme": "Geopolitical Risk and Supply Chain Resilience",
      "factor_scores": {
        "value": -0.06666666666666667,
        "quality": 0.5,
        "growth": 0.5,
        "stability": 0.5,
        "revisions": 0.9,
        "momentum": -0.208198887557235
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Buy",
        "analyst_score": 0.8,
        "news_sentiment": "bullish",
        "news_score": 0.4,
        "key_drivers": [
          "Strong analyst consensus with 80% Buy recommendations",
          "Recent upgrade to Buy from analysts",
          "Recognition for exceptional customer service"
        ],
        "key_risks": [
          "Significant share dump by Yiheng Capital",
          "Bearish sentiment from Goldman Sachs portfolio update"
        ],
        "price_target_upside": -38.69610438729199
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.22024449741790947,
      "news_summary": "Planet Fitness (PLNT) has been recognized for exceptional customer service, earning a spot on USA Today's America's Best Customer Service List for 2026. The stock has recently been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about its earnings prospects, with shares up approximately 9% over the past three months. However, Yiheng Capital has divested 270,000 shares, indicating some fund downsizing amidst these positive developments. Overall, Planet Fitness continues to demonstrate strong performance and customer engagement, positioning itself favorably in the market.",
      "price": 105.76,
      "market_cap": 8809.719493872797,
      "scored_at": "2026-01-09T06:26:55.678358"
    },
    {
      "ticker": "IBM",
      "sector": "Information Technology",
      "theme": null,
      "factor_scores": {
        "value": 0.033333333333333326,
        "quality": 0.35,
        "growth": 0.0,
        "stability": 0.0,
        "revisions": 0.29047619047619044,
        "momentum": 0.18314709159042708
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Hold",
        "analyst_score": 0.2,
        "news_sentiment": "bullish",
        "news_score": 0.4,
        "key_drivers": [
          "Positive outlook on AI tailwinds and enterprise spending stabilization",
          "Analyst recognition of IBM as a top pick for 2026",
          "Expansion of collaboration with Datavault AI for enterprise-grade AI solutions"
        ],
        "key_risks": [
          "Majority of analysts recommend a Hold, indicating caution",
          "Limited technical indicators available for further analysis",
          "Potential market volatility affecting stock performance"
        ],
        "price_target_upside": 2.028276955602532
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.21178251456553052,
      "news_summary": "IBM has been recognized as a top stock pick for 2026, with RBC Capital Markets raising its price target to $350, citing potential AI tailwinds as enterprise spending stabilizes. The company's long-term partnership with Wimbledon has been renewed, leveraging AI and cloud technologies to enhance fan experiences. Additionally, IBM's acquisition of Confluent is expected to boost its EBITDA and free cash flow, further solidifying its position in the big data sector. Overall, IBM is positioned to benefit from the growing demand for AI solutions across various industries.",
      "price": 302.72,
      "market_cap": 282963.04067236994,
      "scored_at": "2026-01-09T06:23:22.462538"
    },
    {
      "ticker": "LMT",
      "sector": "Industrials",
      "theme": "Labor Market Dynamics and Wage Growth",
      "factor_scores": {
        "value": 0.26666666666666666,
        "quality": 0.2,
        "growth": 0.2,
        "stability": 0.0,
        "revisions": 0.3173913043478261,
        "momentum": 0.5990654785287496
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.1,
        "analyst_consensus": "Hold",
        "analyst_score": 0.1,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Defense stocks rally indicating positive market sentiment for LMT",
          "Focus on real-time trajectory simulations and advanced integration in defense sector"
        ],
        "key_risks": [
          "Concerns over trade deficit impacting defense spending",
          "Bearish outlook from some analysts regarding military policy changes"
        ],
        "price_target_upside": 1.892215106859028
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.2095483216138604,
      "news_summary": "Lockheed Martin (LMT) has seen a rally in its stock price following President Trump's proposal to increase the defense budget to $1.5 trillion for fiscal 2027, signaling strong demand in the defense sector. This development comes amid a mixed performance in U.S. equity markets, with defense stocks generally benefiting from heightened military spending discussions. Additionally, analysts are assessing the implications of Trump's comments on CEO pay and their potential impact on LMT's financial strategies. Overall, the defense industry is experiencing increased volatility and opportunities driven by geopolitical tensions and government spending plans.",
      "price": 518.44,
      "market_cap": 119965.87250627344,
      "scored_at": "2026-01-09T06:23:58.716744"
    },
    {
      "ticker": "CVS",
      "sector": "Health Care",
      "theme": "Healthcare Innovation and Biotech Advancements",
      "factor_scores": {
        "value": 0.36666666666666664,
        "quality": -0.4,
        "growth": 0.0,
        "stability": 0.5,
        "revisions": 0.8307692307692307,
        "momentum": 0.1302083333333328
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Buy",
        "analyst_score": 0.7,
        "news_sentiment": "bullish",
        "news_score": 0.4,
        "key_drivers": [
          "Strong analyst consensus with 73.1% Buy recommendations",
          "Recent partnerships expanding healthcare access, indicating growth potential",
          "Positive outlook on dividend stability combined with innovative healthcare solutions"
        ],
        "key_risks": [
          "Recent larger drop in stock price compared to the general market",
          "Market volatility affecting investor sentiment",
          "Potential challenges in maintaining dividend stability amidst market fluctuations"
        ],
        "price_target_upside": 18.312655086848643
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.19325778388278383,
      "news_summary": "CVS Health (CVS) has recently declared a quarterly dividend of $0.665 per share, payable on February 2, 2026, while also advancing its AI-driven healthcare initiatives and expanding its pharmacy benefit management services. Despite a recent drop of 1.13% in stock price to $79.79, CVS has seen a significant 83.2% increase in share value over the past year, prompting investors to reassess its valuation. The company's recent performance shows mixed trends, with a 6.3% return over the last month but a negative 0.5% return over the past three years, indicating potential volatility ahead.",
      "price": 80.6,
      "market_cap": 102316.2602808472,
      "scored_at": "2026-01-09T06:26:23.737607"
    },
    {
      "ticker": "DIS",
      "sector": "Communication Services",
      "theme": null,
      "factor_scores": {
        "value": 0.5,
        "quality": 0.2,
        "growth": 0.0,
        "stability": 0.5,
        "revisions": 0.7296296296296295,
        "momentum": 0.02929887785297865
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.8,
        "analyst_consensus": "Buy",
        "analyst_score": 0.7,
        "news_sentiment": "bullish",
        "news_score": 0.9,
        "key_drivers": [
          "Strong analyst consensus with 66.7% recommending 'Buy'",
          "Positive news regarding CEO's engagement in US-China relations",
          "Outperformance of Disney stock compared to the broader market"
        ],
        "key_risks": [
          "Potential impacts of US-China tensions on business operations",
          "Market volatility affecting stock performance",
          "Dependence on successful execution of new initiatives"
        ],
        "price_target_upside": -38.56091792940353
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.18516943510058276,
      "news_summary": "Disney CEO Bob Iger recently met with a top Chinese official, signaling the company's intent to strengthen its presence in China amid ongoing U.S.-China tensions. Analysts note that while Hollywood films account for only a small portion of China's box office, Disney's theme parks remain a significant profit driver. The stock has shown resilience, closing at $114.17, reflecting an 8.3% increase over the past month, suggesting a positive shift in investor sentiment. Overall, Disney's strategic focus on international expansion and its robust theme park business position it as a strong long-term investment.",
      "price": 114.17,
      "market_cap": 203826.431003093,
      "scored_at": "2026-01-09T06:22:39.735767"
    },
    {
      "ticker": "TXN",
      "sector": "Information Technology",
      "theme": null,
      "factor_scores": {
        "value": -0.19999999999999998,
        "quality": 0.85,
        "growth": -0.5,
        "stability": 0.5,
        "revisions": 0.23157894736842108,
        "momentum": 0.7185812823025333
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.1,
        "analyst_consensus": "Hold",
        "analyst_score": 0.0,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Texas Instruments is attracting investor attention.",
          "Participation in CES 2026 highlights commitment to sustainable energy solutions."
        ],
        "key_risks": [
          "Recent dip in stock price compared to broader market.",
          "Mixed analyst recommendations with a significant portion holding."
        ],
        "price_target_upside": -0.1857256566728545
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.18368804354143967,
      "news_summary": "Texas Instruments (TXN) recently closed at $185.71, reflecting a 3.33% decline amid broader market fluctuations, despite a 6.2% year-to-date return. The company is gaining investor attention ahead of its Q4 2025 earnings call scheduled for January 27, which may provide insights into its financial performance. Additionally, TXN participated in discussions at CES 2026 focused on sustainable energy solutions, highlighting its role in the semiconductor industry. Overall, investor sentiment appears cautious, with some analysts predicting continued negative sentiment in the near term.",
      "price": 188.45,
      "market_cap": 171230.00787221178,
      "scored_at": "2026-01-09T06:23:53.655609"
    },
    {
      "ticker": "CSX",
      "sector": "Industrials",
      "theme": "Infrastructure Spending Surge",
      "factor_scores": {
        "value": 0.6,
        "quality": 0.5,
        "growth": -0.5,
        "stability": 0.5,
        "revisions": 0.7818181818181817,
        "momentum": -0.21379310344827576
      },
      "sentiment": {
        "overall_sentiment": "bearish",
        "sentiment_score": -0.5,
        "analyst_consensus": "Buy",
        "analyst_score": 0.68,
        "news_sentiment": "bearish",
        "news_score": -0.6,
        "key_drivers": [
          "Strong analyst buy consensus",
          "Potential for recovery in logistics sector"
        ],
        "key_risks": [
          "Recent layoffs indicating operational challenges",
          "Negative news affecting market perception",
          "Broader economic concerns in logistics and manufacturing"
        ],
        "price_target_upside": 9.711211778029444
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.17856396477086134,
      "news_summary": "CSX Corporation has recently laid off approximately 5% of its management staff, totaling 166 workers, and furloughed several conductors, citing current market conditions and cost structure evaluations. This move comes amid broader challenges in the U.S. logistics and manufacturing sectors, which have seen over 2,000 layoffs at the start of 2026. Despite these setbacks, CSX's share price has shown resilience, trading just under $37, with a total shareholder return of about 14% over the past year, prompting discussions about its valuation and investment potential.",
      "price": 35.32,
      "market_cap": 65770.67609803937,
      "scored_at": "2026-01-09T06:26:49.332199"
    },
    {
      "ticker": "CVX",
      "sector": "Energy",
      "theme": null,
      "factor_scores": {
        "value": 0.5666666666666667,
        "quality": 0.09999999999999998,
        "growth": -0.5,
        "stability": 0.0,
        "revisions": 0.5800000000000001,
        "momentum": 0.3739912079259893
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.4,
        "analyst_consensus": "Buy",
        "analyst_score": 0.5,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Strong analyst consensus with 52% Buy recommendations",
          "Recent bullish news regarding oil supply concerns in Iran",
          "Potential revitalization of Venezuela's energy sector"
        ],
        "key_risks": [
          "Bearish news regarding challenges in reviving Venezuela's oil sector",
          "Political uncertainty surrounding US-Venezuela relations",
          "Volatility in crude oil prices"
        ],
        "price_target_upside": 9.400313971742543
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.16669799402822172,
      "news_summary": "Chevron (CVX) is actively participating in discussions with the U.S. government regarding potential investments to revitalize Venezuela's struggling oil sector, alongside other major oil companies. Bernstein recently raised its price target for Chevron to $172, reflecting a balanced outlook for oil despite anticipated near-term volatility. Additionally, crude oil prices have been influenced by civil unrest in Iran and U.S. sanctions on Russian oil, contributing to a positive trend in energy stocks. As competition intensifies for Venezuelan oil sales, Chevron is positioning itself strategically in the evolving market landscape.",
      "price": 159.25,
      "market_cap": 320653.3095217655,
      "scored_at": "2026-01-09T06:21:50.167127"
    },
    {
      "ticker": "DE",
      "sector": "Industrials",
      "theme": null,
      "factor_scores": {
        "value": 0.13333333333333333,
        "quality": 0.35,
        "growth": -0.5,
        "stability": -0.3,
        "revisions": 0.6555555555555556,
        "momentum": 0.6305890270707595
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Buy",
        "analyst_score": 0.6,
        "news_sentiment": "bullish",
        "news_score": 0.4,
        "key_drivers": [
          "Strong analyst consensus with 55.6% recommending 'Buy'",
          "Recent expansion with Tenna deal leading to lifted price targets",
          "Positive news regarding stock performance above $500"
        ],
        "key_risks": [
          "Recent news indicating a steeper decline than the broader market",
          "Potential impact of Supreme Court's tariff ruling on market sentiment",
          "Concerns about market volatility affecting stock performance"
        ],
        "price_target_upside": 5.730830670926515
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.1630968319769145,
      "news_summary": "Deere & Company (NYSE: DE) recently saw its stock close above $500, driven by positive market sentiment and a notable acquisition of construction technology firm Tenna, which aims to enhance operational efficiency for contractors. However, the stock experienced a decline of 2.22% in a recent trading session, reflecting some volatility amid broader market trends. Analysts have been reassessing Deere's valuation as momentum cools, with a focus on its recent performance and future growth potential, particularly in technology adoption among farmers. Overall, investor interest remains high as the company navigates these developments.",
      "price": 500.8,
      "market_cap": 135439.07711184176,
      "scored_at": "2026-01-09T06:24:16.640257"
    },
    {
      "ticker": "COST",
      "sector": "Consumer Staples",
      "theme": null,
      "factor_scores": {
        "value": -0.5,
        "quality": 0.19999999999999998,
        "growth": 0.2,
        "stability": 0.0,
        "revisions": 0.5666666666666667,
        "momentum": 0.5118823975075562
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Buy",
        "analyst_score": 0.5,
        "news_sentiment": "bullish",
        "news_score": 0.4,
        "key_drivers": [
          "Strong analyst consensus with 50% Buy recommendations",
          "Positive news headlines indicating strong performance and consumer sentiment",
          "Significant price target upside potential"
        ],
        "key_risks": [
          "Potential impact of tariffs on costs and margins",
          "Market volatility affecting stock performance",
          "Limited technical indicators for further analysis"
        ],
        "price_target_upside": 11.992658225082211
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.15453408242099473,
      "news_summary": "Costco Wholesale reported strong December same-store sales, indicating robust growth as the company closed 2025 on a high note, contributing to a 150% increase in stock value over the past five years. The positive sales performance has led to a notable rise in Costco's stock price, reflecting investor confidence in the retail giant's continued success. As consumer stocks generally performed well, Costco's strong sales figures position it favorably in the market amidst mixed equity index trends.",
      "price": 915.31,
      "market_cap": 406278.12236951775,
      "scored_at": "2026-01-09T06:22:17.386728"
    },
    {
      "ticker": "T",
      "sector": "Communication Services",
      "theme": null,
      "factor_scores": {
        "value": 0.7999999999999999,
        "quality": 0.35,
        "growth": -0.5,
        "stability": 0.5,
        "revisions": 0.5583333333333333,
        "momentum": -0.22477187332259732
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Buy",
        "analyst_score": 0.5,
        "news_sentiment": "bullish",
        "news_score": 0.5,
        "key_drivers": [
          "Strong analyst consensus with 50% Buy recommendations",
          "Positive news regarding AT&T's role in automotive connectivity",
          "Bullish sentiment from multiple news articles highlighting future growth potential"
        ],
        "key_risks": [
          "Concerns over a potential wireless price war",
          "Market volatility affecting stock performance",
          "Limited technical indicators to support price movement"
        ],
        "price_target_upside": -39.65659908978072
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.1258045139687652,
      "news_summary": "AT&T (T) is enhancing its position in the automotive sector by partnering with Mitsubishi Motors to provide 5G connectivity for the 2026 Mitsubishi Outlander, which will feature advanced in-car technology. However, concerns are rising over a potential wireless price war among major telecom players, including AT&T, T-Mobile, and Verizon, which could impact profitability. Additionally, AT&T's recent earnings growth and dividend potential are drawing interest from investors, despite competitive pressures in the market.",
      "price": 24.17,
      "market_cap": 171351.9945107927,
      "scored_at": "2026-01-09T06:22:51.144429"
    },
    {
      "ticker": "VRTX",
      "sector": "Health Care",
      "theme": null,
      "factor_scores": {
        "value": -0.6,
        "quality": 0.19999999999999998,
        "growth": 0.5,
        "stability": 0.0,
        "revisions": 0.6862068965517241,
        "momentum": 0.29998235397917755
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.1,
        "analyst_consensus": "Buy",
        "analyst_score": 0.3,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Strong analyst consensus with 58.6% recommending a Buy",
          "Attracting investor attention despite recent challenges"
        ],
        "key_risks": [
          "Recent bearish news regarding market performance and growth challenges",
          "Rating downgrade concerns"
        ],
        "price_target_upside": 3.9218191108840097
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.1224950546229822,
      "news_summary": "Vertex Pharmaceuticals (VRTX) experienced a decline of 2.99% to close at $469.68 amid broader market gains. Despite recent attention from investors and an upgrade from Wolfe Research to 'Outperform' with a $548 price target, the company's growth remains modest, particularly in its cystic fibrosis segment. Analysts are increasingly focusing on Vertex's investigational IgA nephropathy therapy as a potential driver for future growth. Overall, the stock is currently rated as a 'hold' by some analysts, reflecting cautious optimism about its pipeline developments.",
      "price": 469.68,
      "market_cap": 119166.65683179875,
      "scored_at": "2026-01-09T06:25:17.643938"
    },
    {
      "ticker": "VMC",
      "sector": "Materials",
      "theme": "Infrastructure Spending Surge",
      "factor_scores": {
        "value": 0.03333333333333335,
        "quality": 0.35,
        "growth": -0.5,
        "stability": 0.0,
        "revisions": 0.65,
        "momentum": 0.4064114250987532
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.3,
        "analyst_consensus": "Buy",
        "analyst_score": 0.5,
        "news_sentiment": "bearish",
        "news_score": -0.2,
        "key_drivers": [
          "Strong analyst consensus with 55% Buy recommendations",
          "Positive outlook from Jim Cramer regarding investment opportunities",
          "Potential for growth in the materials sector as indicated by competitors"
        ],
        "key_risks": [
          "Recent bearish news highlighting concerns about returns on capital",
          "Market sentiment indicating potential risks in unpopular stocks",
          "General economic uncertainties affecting the materials sector"
        ],
        "price_target_upside": 7.645505298699564
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.11855927421105172,
      "news_summary": "Vulcan Materials (NYSE: VMC) has recently faced challenges, with returns on capital reportedly slowing down, raising concerns about its growth potential. Despite this, the stock has shown resilience, outperforming competitors on strong trading days. The broader construction materials sector is benefiting from increased infrastructure investment, which may provide VMC with opportunities for recovery. Analysts are closely watching the company's ability to navigate these trends amidst competition from peers like Martin Marietta Materials, which is positioned for growth driven by residential recovery and margin expansion.",
      "price": 299.13,
      "market_cap": 39524.316997637405,
      "scored_at": "2026-01-09T06:26:41.965006"
    },
    {
      "ticker": "UPS",
      "sector": "Industrials",
      "theme": "Geopolitical Risk and Supply Chain Resilience",
      "factor_scores": {
        "value": 0.36666666666666664,
        "quality": 0.2,
        "growth": 0.0,
        "stability": 0.5,
        "revisions": 0.26,
        "momentum": 0.6536277178479014
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.0,
        "analyst_consensus": "Hold",
        "analyst_score": 0.0,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "UPS has surpassed market returns recently, indicating strong performance.",
          "Bullish sentiment from some analysts and news articles."
        ],
        "key_risks": [
          "Downgrades from Wolfe Research due to concerns over Amazon volume cuts.",
          "Margin pressure highlighted in recent reports."
        ],
        "price_target_upside": -6.328877255305223
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.10041635630440378,
      "news_summary": "United Parcel Service (UPS) recently reported quarterly earnings that surpassed analyst expectations, driven by its Efficiency Reimagined turnaround plan, which focuses on reducing low-margin Amazon business in favor of higher-margin deliveries. However, Wolfe Research downgraded UPS to Peer Perform, citing challenges in the first half of 2026 due to ongoing margin pressures and decreased Amazon volume. Despite a recent stock increase of 1.48%, concerns about future performance and competition from other dividend-paying stocks like WAB are emerging as significant factors for investors to consider.",
      "price": 106.97,
      "market_cap": 90751.81038616547,
      "scored_at": "2026-01-09T06:24:21.762169"
    },
    {
      "ticker": "ORCL",
      "sector": "Information Technology",
      "theme": null,
      "factor_scores": {
        "value": -0.39999999999999997,
        "quality": 0.5,
        "growth": 0.2,
        "stability": 0.5,
        "revisions": 0.6555555555555556,
        "momentum": -0.22489012022642893
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Buy",
        "analyst_score": 0.6,
        "news_sentiment": "bullish",
        "news_score": 0.4,
        "key_drivers": [
          "Strong analyst support with a majority recommending 'Buy'",
          "Positive news from UBS indicating a recovery path despite target cut",
          "Bullish sentiment from recent valuation checks and joint ventures"
        ],
        "key_risks": [
          "Concerns raised by Jim Cramer regarding Oracle's business model",
          "Recent bearish news affecting stock performance",
          "Market volatility impacting tech stocks"
        ],
        "price_target_upside": -17.397838122857898
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.0755343328992706,
      "news_summary": "Oracle Corporation (NYSE:ORCL) is facing mixed sentiment as UBS maintains a 'Buy' rating but lowers its price target from $325 to $280, citing potential recovery linked to OpenAI developments. Meanwhile, Jim Cramer expressed skepticism about Oracle's business model, particularly regarding its debt incurred for data center expansions. The stock recently experienced a 2.2% decline amid a broader market rotation away from technology, despite a recent rally. Overall, investor sentiment remains cautious as the company navigates challenges in the AI sector.",
      "price": 189.65,
      "market_cap": 544889.0719278781,
      "scored_at": "2026-01-09T06:23:15.618096"
    },
    {
      "ticker": "FDX",
      "sector": "Industrials",
      "theme": null,
      "factor_scores": {
        "value": 0.36666666666666664,
        "quality": -0.25,
        "growth": 0.0,
        "stability": 0.5,
        "revisions": 0.5444444444444444,
        "momentum": 0.5813081308130806
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Buy",
        "analyst_score": 0.6,
        "news_sentiment": "bullish",
        "news_score": 0.2,
        "key_drivers": [
          "Strong analyst consensus with 51.9% recommending a buy",
          "Positive news regarding FedEx's strategic pivot towards B2B services",
          "Current price is above the price target indicating potential for correction"
        ],
        "key_risks": [
          "Bearish news regarding external factors affecting the shipping industry",
          "High competition in the logistics sector",
          "Potential regulatory impacts from tariff rulings"
        ],
        "price_target_upside": -8.624316365166168
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.05891129239534139,
      "news_summary": "FedEx (FDX) is experiencing a strategic shift towards premium business-to-business (B2B) shipping, recently securing contracts with major clients like BMW Group, which could enhance its profitability and service quality. The company is also focusing on operational efficiency through its DRIVE and Network 2.0 programs, supporting its growth in high-value verticals. Additionally, FedEx's stock has shown strong performance compared to competitors, indicating positive market sentiment amid these developments.",
      "price": 309.01,
      "market_cap": 72655.29881397187,
      "scored_at": "2026-01-09T06:24:27.267975"
    },
    {
      "ticker": "BRK.B",
      "sector": "Financials",
      "theme": null,
      "factor_scores": {
        "value": 0.4666666666666667,
        "quality": 0.09999999999999998,
        "growth": -0.5,
        "stability": 0.5,
        "revisions": -0.2857142857142857,
        "momentum": 0.07357091026364543
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.0,
        "analyst_consensus": "Hold",
        "analyst_score": 0.0,
        "news_sentiment": "bullish",
        "news_score": 0.2,
        "key_drivers": [
          "Berkshire Hathaway remains heavily undervalued with a new CEO.",
          "Positive sentiment around early retirement strategies."
        ],
        "key_risks": [
          "Concerns about potential turbulence in 2026.",
          "Mixed analyst recommendations with a significant portion advising sell."
        ],
        "price_target_upside": null
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.041371857404844795,
      "news_summary": "Berkshire Hathaway has recently undergone a leadership transition with Greg Abel taking over as CEO from Warren Buffett, who remains as chair. Despite this change, analysts suggest that the company is undervalued, with a market cap of $1.1 trillion compared to an estimated intrinsic value of $1.8 trillion, bolstered by strong energy growth and cash flexibility. However, the company faces challenges in 2026, including rising claims costs at GEICO and pressure on margins due to CEO transition and interest income declines from Federal Reserve cuts. Abel's new compensation package has been set at $25 million, reflecting the company's commitment to maintaining strong leadership.",
      "price": 499.77,
      "market_cap": 1078343.1921431476,
      "scored_at": "2026-01-09T06:20:59.565353"
    },
    {
      "ticker": "CRM",
      "sector": "Information Technology",
      "theme": null,
      "factor_scores": {
        "value": -0.06666666666666665,
        "quality": 0.35,
        "growth": 0.2,
        "stability": 0.0,
        "revisions": 0.7976744186046512,
        "momentum": -0.13778264316183017
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.3,
        "analyst_consensus": "Buy",
        "analyst_score": 0.7,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Strong analyst consensus with 69.8% recommending Buy",
          "Positive news regarding Salesforce's recognition in consulting services",
          "Potential for rebound in tech stocks"
        ],
        "key_risks": [
          "Recent bearish news indicating market pressure on tech stocks",
          "Salesforce stock decline despite market gains",
          "Overall tech weakness impacting sentiment"
        ],
        "price_target_upside": -37.78643534333857
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.03051902511337166,
      "news_summary": "Salesforce.com (CRM) experienced a decline of 2.11%, closing at $260.5 amid broader market pressures, particularly in the tech sector. Despite a challenging 2025, analysts suggest that Salesforce, along with other tech stocks, may be poised for a rebound in 2026. Additionally, Salesforce consulting services are gaining recognition, with firms like West Monroe and OSF Digital being highlighted in recent industry assessments. The overall sentiment indicates a cautious optimism for Salesforce's future performance as it navigates a competitive landscape.",
      "price": 260.53,
      "market_cap": 244116.60552110043,
      "scored_at": "2026-01-09T06:23:34.765379"
    },
    {
      "ticker": "NKE",
      "sector": "Consumer Discretionary",
      "theme": "Consumer Behavior Shifts Post-Pandemic",
      "factor_scores": {
        "value": -0.09999999999999999,
        "quality": 0.0,
        "growth": -0.5,
        "stability": 0.0,
        "revisions": 0.50625,
        "momentum": 0.20274158949406218
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Buy",
        "analyst_score": 0.6,
        "news_sentiment": "bullish",
        "news_score": 0.4,
        "key_drivers": [
          "Strong analyst consensus with 46.9% Buy recommendations",
          "Recent news highlights a path to profitable growth despite target reduction",
          "Positive comparisons with other high-quality dividend growth stocks"
        ],
        "key_risks": [
          "Recent downgrade by Needham raises concerns",
          "Market volatility and external factors affecting retail",
          "Potential impact of tariff rulings on profitability"
        ],
        "price_target_upside": 17.36132393502911
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.029297218547336284,
      "news_summary": "RBC Capital Markets has lowered its price target for Nike (NKE) from $85 to $78 while maintaining an Outperform rating, citing that the company's path to profitable growth remains intact despite a stretched timeline. Additionally, Needham & Company has downgraded Nike, reflecting a cautious outlook amid a challenging retail environment. Recent trading indicates slight declines in Nike's stock as investors assess slowing demand in China against broader brand renewal efforts. Overall, the apparel and footwear sector is expected to improve in 2026, driven by a resilient consumer and easing tariff pressures.",
      "price": 65.26,
      "market_cap": 96609.83595847359,
      "scored_at": "2026-01-09T06:24:32.246218"
    },
    {
      "ticker": "FLR",
      "sector": "Industrials",
      "theme": "Infrastructure Spending Surge",
      "factor_scores": {
        "value": 0.4666666666666667,
        "quality": -0.4,
        "growth": 0.2,
        "stability": 0.0,
        "revisions": 0.6454545454545454,
        "momentum": 0.8011607368155427
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Buy",
        "analyst_score": 0.5,
        "news_sentiment": "bullish",
        "news_score": 0.4,
        "key_drivers": [
          "Strong analyst consensus with 54.5% recommending 'Buy'",
          "Recent bullish news regarding Fluor's project completions and valuation",
          "Positive sentiment from shareholder activism indicating potential for growth"
        ],
        "key_risks": [
          "No technical indicators available to support price movement",
          "Market volatility could impact stock performance",
          "Potential uncertainties in project execution and delivery timelines"
        ],
        "price_target_upside": -35.543278084714544
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.026606499732919064,
      "news_summary": "Fluor Corporation (FLR) recently achieved mechanical completion on BASF's new Verbund site project in South China, signaling progress in its project portfolio. The stock has seen an 11% increase over the past week, although it remains down 11.2% year-over-year, reflecting mixed performance trends. Analysts suggest that Fluor's growing backlog, including a significant rare earth magnet manufacturing plant in Texas, may present a buying opportunity for investors. The company is set to hold a fourth-quarter earnings conference call on February 17, 2026, which could provide further insights into its financial outlook.",
      "price": 43.44,
      "market_cap": 7001.767828372974,
      "scored_at": "2026-01-09T06:26:36.204441"
    },
    {
      "ticker": "ILMN",
      "sector": "Health Care",
      "theme": "Healthcare Innovation and Biotech Advancements",
      "factor_scores": {
        "value": 0.7,
        "quality": 0.05000000000000002,
        "growth": -0.5,
        "stability": 0.0,
        "revisions": 0.3222222222222222,
        "momentum": 0.932067703568162
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.5,
        "analyst_consensus": "Hold",
        "analyst_score": 0.2,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Appointment of Dr. Eric Green as Chief Medical Officer",
          "Partnership with PREMIA to expand clinical access in Asia",
          "Positive market projections for biotechnology instruments"
        ],
        "key_risks": [
          "Majority of analysts recommend Hold, indicating caution",
          "Recent share price rebound may not be sustainable",
          "Potential competition in the biotechnology sector"
        ],
        "price_target_upside": -17.02667489542619
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": 0.006024388000600302,
      "news_summary": "Illumina, Inc. (NASDAQ: ILMN) has appointed Dr. Eric Green as Chief Medical Officer to enhance its focus on genomics and precision medicine. The company's share price has recently rebounded, closing at $150.14, with mixed performance metrics indicating both short-term gains and long-term challenges. Additionally, Illumina has formed a strategic partnership with PREMIA to expand access to comprehensive genomic profiling in Asia, while also advancing its divestiture plan for its cancer-diagnostics unit to streamline operations and reduce regulatory pressures.",
      "price": 145.83,
      "market_cap": 22282.824354522112,
      "scored_at": "2026-01-09T06:26:29.901507"
    },
    {
      "ticker": "TSLA",
      "sector": "Consumer Discretionary",
      "theme": "Energy Transition and Sustainability",
      "factor_scores": {
        "value": -0.5,
        "quality": -0.25,
        "growth": 0.0,
        "stability": 0.5,
        "revisions": 0.32000000000000006,
        "momentum": -0.2579382727030155
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Hold",
        "analyst_score": 0.2,
        "news_sentiment": "bullish",
        "news_score": 0.6,
        "key_drivers": [
          "Partnerships in self-driving technology with Nvidia and auto suppliers",
          "Innovations in wireless charging for electric vehicles",
          "Positive market sentiment around AI investments"
        ],
        "key_risks": [
          "High competition in the electric vehicle market",
          "Potential volatility in stock price due to market speculation",
          "Concerns over CEO's focus on AI investments affecting core business"
        ],
        "price_target_upside": 6.739329967875173
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": -0.00323515584300073,
      "news_summary": "Tesla (TSLA) continues to attract attention as it recently closed at $435.8, reflecting a modest gain of 1.02%. The company's valuation remains heavily influenced by its ambitious Full Self-Driving (FSD) and Robotaxi initiatives, which analysts describe as a high-risk proposition. Additionally, CEO Elon Musk's xAI startup reported significant cash burn, totaling nearly $8 billion, as it aims to develop advanced AI technologies, including humanoid robots. Notably, hedge fund manager Israel Englander has shifted his investments towards Tesla, indicating confidence in the company's future prospects.",
      "price": 435.8,
      "market_cap": 1449392.0789047005,
      "scored_at": "2026-01-09T06:20:47.236008"
    },
    {
      "ticker": "ENPH",
      "sector": "Utilities",
      "theme": "Energy Transition and Sustainability",
      "factor_scores": {
        "value": -0.06666666666666665,
        "quality": 0.0,
        "growth": -0.5,
        "stability": 0.0,
        "revisions": 0.07142857142857145,
        "momentum": 0.878835153406137
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.0,
        "analyst_consensus": "Hold",
        "analyst_score": 0.0,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Market is overlooking potential tailwinds",
          "Focus on inventory discipline and cash management"
        ],
        "key_risks": [
          "Recent stock performance worse than broader market",
          "Concerns from analysts about cash-heavy stocks"
        ],
        "price_target_upside": 6.040079029071411
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": -0.0592844938287327,
      "news_summary": "Enphase Energy (ENPH) has faced recent challenges, including a significant drop in stock price, closing at $32.18, down 2.87% in the latest trading session. Despite these headwinds, the company is focusing on inventory discipline and cash generation, which may position it for a rebound by late 2026. Analysts note a recent 24% share price rebound over the past month, indicating a potential reassessment of the company's growth prospects amidst a mixed solar market sentiment. Investors are encouraged to monitor Enphase's strategic shifts and operational focus as it navigates near-term pressures while aiming for long-term growth in the residential solar sector.",
      "price": 35.43,
      "market_cap": 4636.359366074374,
      "scored_at": "2026-01-09T06:25:53.989802"
    },
    {
      "ticker": "BA",
      "sector": "Industrials",
      "theme": null,
      "factor_scores": {
        "value": -0.6,
        "quality": -0.4,
        "growth": -0.5,
        "stability": 0.5,
        "revisions": 0.85,
        "momentum": 0.3937914517317609
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Buy",
        "analyst_score": 0.75,
        "news_sentiment": "bullish",
        "news_score": 0.4,
        "key_drivers": [
          "Strong analyst consensus with 75% Buy recommendations",
          "Positive news regarding defense spending plans indicating strong demand",
          "Recent bullish articles highlighting backlog strength and valuation"
        ],
        "key_risks": [
          "Bearish sentiment from Karman Holdings news",
          "Potential volatility in defense spending due to political changes",
          "Market uncertainty affecting aerospace sector"
        ],
        "price_target_upside": 9.596270560295537
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": -0.07172421658420186,
      "news_summary": "Boeing (BA) has seen a recent uptick in its share price, closing at $228.12, with a 5.1% increase over the past week and a 32.8% rise over the last year, indicating a recovery trend for the stock. This momentum coincides with President Trump's proposal for a $1.5 trillion defense budget, which has positively impacted defense stocks, including Boeing. Additionally, Alaska Airlines has placed a significant order for Boeing aircraft, further supporting the company's growth prospects. Investors are reassessing Boeing's valuation in light of these developments and its overall return profile.",
      "price": 227.38,
      "market_cap": 178054.73201766313,
      "scored_at": "2026-01-09T06:24:05.177268"
    },
    {
      "ticker": "TGT",
      "sector": "Consumer Discretionary",
      "theme": "Labor Market Dynamics and Wage Growth",
      "factor_scores": {
        "value": 0.36666666666666664,
        "quality": 0.0,
        "growth": -0.5,
        "stability": 0.0,
        "revisions": 0.2142857142857143,
        "momentum": 0.7314578005115088
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.6,
        "analyst_consensus": "Hold",
        "analyst_score": 0.2,
        "news_sentiment": "bullish",
        "news_score": 0.7,
        "key_drivers": [
          "Strong bullish sentiment from recent news articles highlighting Target's brand narrative and dividend yield.",
          "Positive market performance relative to competitors.",
          "High yield attracting income-focused investors."
        ],
        "key_risks": [
          "Current consensus rating of Hold indicates caution among analysts.",
          "Potential market volatility affecting stock performance.",
          "Concerns about long-term growth amidst economic uncertainties."
        ],
        "price_target_upside": -10.382770619768637
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": -0.07491924305954267,
      "news_summary": "Target Corporation (TGT) has seen a significant decline of 28% in 2025, positioning it as a potential value stock for investors seeking high-yield dividends, currently offering a 4.5% yield. In early January 2026, the company announced a 30% expansion of its wellness product assortment, aiming to reframe its brand narrative and attract consumers. Despite recent market fluctuations, TGT's stock closed at $106.33, reflecting a 2.57% increase, while analysts remain cautious, with Wolfe Research maintaining an Underperform rating amid activist investor interest. Overall, Target's strategic initiatives and dividend appeal may attract patient investors looking for long-term growth.",
      "price": 106.33,
      "market_cap": 48146.90328736394,
      "scored_at": "2026-01-09T06:24:55.085666"
    },
    {
      "ticker": "AMD",
      "sector": "Information Technology",
      "theme": "AI Infrastructure Buildout",
      "factor_scores": {
        "value": -0.39999999999999997,
        "quality": -0.25,
        "growth": 0.5,
        "stability": 0.0,
        "revisions": 0.7904761904761904,
        "momentum": -0.3688830780724688
      },
      "sentiment": {
        "overall_sentiment": "bullish",
        "sentiment_score": 0.4,
        "analyst_consensus": "Buy",
        "analyst_score": 0.69,
        "news_sentiment": "bearish",
        "news_score": -0.2,
        "key_drivers": [
          "Strong analyst consensus with 69% Buy recommendations",
          "Partnership with KunlunMeta highlights growth potential",
          "Positive mention in technology stock recommendations"
        ],
        "key_risks": [
          "Concerns over high P/E ratio",
          "Recent bearish news impacting market perception",
          "Overall market volatility affecting tech stocks"
        ],
        "price_target_upside": -28.385772913816687
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": -0.11609193795809944,
      "news_summary": "At CES 2026, AMD showcased its advancements in AI technology, highlighting its strategic positioning in the rapidly evolving semiconductor market. Despite a strong one-year return of 68%, AMD's stock has faced a recent pullback, raising questions about its valuation amid fierce competition, particularly from Intel's new gaming chip that threatens AMD's handheld gaming market share. Analysts are closely monitoring AMD's performance as it navigates the challenges of high P/E ratios and shifting market sentiment, especially in light of significant AI demand forecasts exceeding $500 billion.",
      "price": 204.68,
      "market_cap": 333227.54179828626,
      "scored_at": "2026-01-09T06:23:02.235847"
    },
    {
      "ticker": "SBUX",
      "sector": "Consumer Discretionary",
      "theme": null,
      "factor_scores": {
        "value": -0.3,
        "quality": 0.0,
        "growth": 0.0,
        "stability": 0.5,
        "revisions": 0.4235294117647058,
        "momentum": 0.3928670387523268
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.0,
        "analyst_consensus": "Hold",
        "analyst_score": 0.0,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Positive outlook on high-yield dividend potential",
          "Potential growth from Disney dining return and gamer tie-ins"
        ],
        "key_risks": [
          "Concerns over pricing reflecting mixed returns",
          "Recent performance decline compared to broader market"
        ],
        "price_target_upside": -39.44205035155365
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": -0.14095591131991722,
      "news_summary": "Starbucks (SBUX) has faced challenges with weak sales trends, resulting in a 3.1% decline in stock price to $86.69 recently, alongside a 3.9% decline over the past year. However, the company is seeing potential for a turnaround, bolstered by its reinstatement in Disney's 2026 Dining Plan and new brand partnerships aimed at enhancing customer engagement. Analysts suggest that Starbucks could experience double-digit gains by the end of 2026, despite ongoing debates about its pricing and brand strength. Overall, the stock is currently viewed as a mixed opportunity, with some analysts highlighting it as undervalued while others express caution.",
      "price": 88.18,
      "market_cap": 100269.47867134387,
      "scored_at": "2026-01-09T06:24:49.655775"
    },
    {
      "ticker": "NIO",
      "sector": "Consumer Discretionary",
      "theme": "Energy Transition and Sustainability",
      "factor_scores": {
        "value": -0.6,
        "quality": -0.4,
        "growth": 0.7,
        "stability": 0.5,
        "revisions": 0.475,
        "momentum": -0.6045751633986916
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.1,
        "analyst_consensus": "Hold",
        "analyst_score": 0.1,
        "news_sentiment": "bullish",
        "news_score": 0.2,
        "key_drivers": [
          "Strengthened EV battery ties with CATL amid competitive pricing",
          "Positive outlook on breakeven profitability"
        ],
        "key_risks": [
          "Concerns about consistent profitability",
          "Overall market volatility affecting EV sector"
        ],
        "price_target_upside": -32.029598308668085
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": -0.18831310301898532,
      "news_summary": "NIO has strengthened its partnership with CATL to enhance battery technology and expand battery swapping capabilities in China, amidst a competitive EV market. Despite strong delivery numbers and potential for profitability in Q4 2025, concerns remain regarding profitability, liquidity challenges, and margin pressures. Analysts suggest that NIO stock may be oversold relative to its business progress, but caution persists due to risks associated with the Chinese economy and ongoing lawsuits. Overall, while there are positive developments, the stock is viewed as a hold due to these uncertainties.",
      "price": 4.73,
      "market_cap": 10112.9973747544,
      "scored_at": "2026-01-09T06:25:58.493862"
    },
    {
      "ticker": "INTC",
      "sector": "Information Technology",
      "theme": "AI Infrastructure Buildout",
      "factor_scores": {
        "value": -0.6,
        "quality": -0.4,
        "growth": -0.5,
        "stability": 0.0,
        "revisions": 0.054545454545454564,
        "momentum": 0.9507678410117436
      },
      "sentiment": {
        "overall_sentiment": "neutral",
        "sentiment_score": 0.0,
        "analyst_consensus": "Hold",
        "analyst_score": 0.0,
        "news_sentiment": "neutral",
        "news_score": 0.0,
        "key_drivers": [
          "Launch of next generation AI PCs at CES 2026",
          "Positive attention in stocks to watch recap"
        ],
        "key_risks": [
          "Technology sell-off impacting market sentiment",
          "Bearish news regarding mixed performance of US equity indexes"
        ],
        "price_target_upside": -7.346144490391622
      },
      "risk_flags": {
        "passed_all_checks": true,
        "failed_checks": [],
        "liquidity_ok": true,
        "price_ok": true,
        "no_trading_halts": true,
        "no_pending_ma": true,
        "earnings_clear": true
      },
      "composite_score": -0.3942190021930474,
      "news_summary": "Intel Corporation (NASDAQ: INTC) recently launched its next generation of AI PCs at CES 2026, featuring the Core Ultra Series 3 processors built on the Intel 18A platform, which has generated positive investor sentiment. The stock has seen a rally, hitting a new 52-week high, and is up over 12% year-to-date. However, the broader technology sector faced a sell-off, impacting Intel's shares along with other chipmakers like Nvidia and AMD. Despite this, Intel's advancements in gaming chips and strategic partnerships, such as with Mobileye, position it favorably in the market.",
      "price": 41.11,
      "market_cap": 204924.16159001592,
      "scored_at": "2026-01-09T06:22:56.730775"
    }
  ],
  "scored_at": "2026-01-09T06:27:07.955464",
  "stats": {
    "total_scored": 71,
    "passed_risk_screens": 71,
    "avg_composite_score": 0.25501924543952925,
    "top_10_scores": [
      0.6256431304210766,
      0.6126071295366374,
      0.5769766365101542,
      0.5719965426068285,
      0.5408889450690094,
      0.5176791823378168,
      0.5096491266532992,
      0.49276700067747614,
      0.4896401847106334,
      0.4673676397578405
    ]
  }
}